query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_1322_ESMFold_hypothetical_protein	1mru-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1mru-assembly1.cif.gz_A Intracellular Ser/Thr protein kinase domain of Mycobacterium tuberculosis PknB.	0.194	296	203	176	471	9	261	1.297E-13	470
LOKIASV2_1322_ESMFold_hypothetical_protein	1o6y-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1o6y-assembly1.cif.gz_A Catalytic domain of PknB kinase from Mycobacterium tuberculosis	0.196	307	207	164	470	1	259	3.846E-13	469
LOKIASV2_1322_ESMFold_hypothetical_protein	5u94-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5u94-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PASTA kinase PknB in complex with the potential theraputic kinase inhibitor GSK690693.	0.193	307	211	164	470	1	262	2.066E-13	457
LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly2.cif.gz_B Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	0.198	307	209	164	470	1	261	6.454E-13	449
LOKIASV2_1322_ESMFold_hypothetical_protein	5l4q-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5l4q-assembly2.cif.gz_B Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (AAK1) in Complex with LKB1 (AAK1 Dual Inhibitor)	0.172	306	220	165	470	3	269	7.728E-14	444
LOKIASV2_1322_ESMFold_hypothetical_protein	8gmd-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8gmd-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	0.172	306	229	165	470	7	284	1.680E-13	435
LOKIASV2_1322_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.166	321	243	164	484	1	292	9.506E-14	432
LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly4.cif.gz_D Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	0.192	294	200	176	469	9	257	1.265E-12	430
LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly1.cif.gz_A Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	0.194	306	210	164	469	1	262	1.726E-12	430
LOKIASV2_1322_ESMFold_hypothetical_protein	8gmd-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8gmd-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	0.165	321	245	164	484	1	294	2.176E-13	430
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.219	302	196	169	470	5	256	2.750E-12	427
LOKIASV2_1322_ESMFold_hypothetical_protein	7lvi-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7lvi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-METHOXY-4- (1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	0.177	307	229	164	470	1	279	3.468E-13	425
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2p-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	6b2p-assembly1.cif.gz_A-2 Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.190	295	199	176	470	8	254	2.236E-12	422
LOKIASV2_1322_ESMFold_hypothetical_protein	3orm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3orm-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain D76A mutant	0.198	296	203	176	471	2	255	2.896E-12	422
LOKIASV2_1322_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_B Crystal structure of the human cyclin G associated kinase (GAK)	0.162	313	215	166	478	5	262	2.819E-13	422
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_A Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.215	308	198	163	470	1	253	3.383E-12	421
LOKIASV2_1322_ESMFold_hypothetical_protein	6i2p-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6i2p-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PknB kinase domain (L33E mutant) in complex with its substrate GarA	0.194	301	214	170	470	6	271	5.526E-13	418
LOKIASV2_1322_ESMFold_hypothetical_protein	8gmc-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8gmc-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.171	305	226	166	470	6	279	6.128E-13	415
LOKIASV2_1322_ESMFold_hypothetical_protein	3oro-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3oro-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 4)	0.191	296	210	176	471	3	262	6.454E-13	414
LOKIASV2_1322_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_A Crystal structure of the human cyclin G associated kinase (GAK)	0.153	313	212	166	478	6	256	1.141E-12	412
LOKIASV2_1322_ESMFold_hypothetical_protein	7rj8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7rj8-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-(DIFLUOROM ETHOXY)-4-(1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	0.170	320	244	165	484	3	297	2.819E-13	412
LOKIASV2_1322_ESMFold_hypothetical_protein	5m08-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5m08-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136A double mutant	0.177	308	205	163	470	3	252	3.751E-12	411
LOKIASV2_1322_ESMFold_hypothetical_protein	4c59-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4c59-assembly1.cif.gz_A Structure of GAK kinase in complex with nanobody (NbGAK_4)	0.166	314	211	165	478	3	256	7.158E-13	411
LOKIASV2_1322_ESMFold_hypothetical_protein	5y80-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5y80-assembly1.cif.gz_A Complex structure of cyclin G-associated kinase with gefitinib	0.182	320	242	166	485	7	303	2.414E-13	411
LOKIASV2_1322_ESMFold_hypothetical_protein	5ikw-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5ikw-assembly1.cif.gz_A Crystal Structure of BMP-2-inducible kinase in complex with an Indazole inhibitor	0.179	302	227	167	468	1	277	3.127E-13	408
LOKIASV2_1322_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain	0.185	306	199	163	468	2	246	2.354E-12	405
LOKIASV2_1322_ESMFold_hypothetical_protein	4y8d-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4y8d-assembly2.cif.gz_B Crystal structure of Cyclin-G associated kinase (GAK) complexed with selective 12i inhibitor	0.162	314	209	165	478	3	252	3.212E-12	404
LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly3.cif.gz_C Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	0.180	295	200	176	470	9	253	1.369E-11	402
LOKIASV2_1322_ESMFold_hypothetical_protein	5l4q-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5l4q-assembly1.cif.gz_A Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (AAK1) in Complex with LKB1 (AAK1 Dual Inhibitor)	0.164	306	226	165	470	3	273	1.265E-12	400
LOKIASV2_1322_ESMFold_hypothetical_protein	5te0-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5te0-assembly1.cif.gz_A Crystal Structure of Adaptor Protein 2 Associated Kinase (AAK1) in complex with BIBF 1120	0.180	309	232	161	469	3	286	9.765E-13	399
LOKIASV2_1322_ESMFold_hypothetical_protein	5m07-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5m07-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A mutant	0.185	306	197	163	468	3	245	4.161E-12	396
LOKIASV2_1322_ESMFold_hypothetical_protein	4c57-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4c57-assembly2.cif.gz_B Structure of GAK kinase in complex with a nanobody	0.178	313	241	166	478	4	297	1.403E-12	395
LOKIASV2_1322_ESMFold_hypothetical_protein	3ori-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	3ori-assembly4.cif.gz_D Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 1)	0.194	296	204	176	471	2	255	3.383E-12	393
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.223	301	193	176	476	11	260	5.676E-12	392
LOKIASV2_1322_ESMFold_hypothetical_protein	5m08-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5m08-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136A double mutant	0.184	308	198	163	470	3	246	1.113E-11	390
LOKIASV2_1322_ESMFold_hypothetical_protein	7rj7-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7rj7-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND 2-(1-AMINO-3-METHYLBUTYL)-6- (PYRIDIN-4-YL)QUINOLINE-4-CARBONITRILE	0.173	305	231	165	469	10	289	5.526E-13	386
LOKIASV2_1322_ESMFold_hypothetical_protein	5m09-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5m09-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136N double mutant	0.182	306	196	163	468	2	242	1.369E-11	385
LOKIASV2_1322_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	0.163	309	222	169	477	5	270	2.750E-12	385
LOKIASV2_1322_ESMFold_hypothetical_protein	6l14-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6l14-assembly1.cif.gz_A Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives	0.174	287	202	176	462	6	250	8.588E-12	383
LOKIASV2_1322_ESMFold_hypothetical_protein	5m07-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5m07-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A mutant	0.175	306	199	163	468	3	244	1.867E-11	382
LOKIASV2_1322_ESMFold_hypothetical_protein	6i2p-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6i2p-assembly2.cif.gz_B Crystal structure of the Mycobacterium tuberculosis PknB kinase domain (L33E mutant) in complex with its substrate GarA	0.192	294	206	176	469	10	265	5.390E-12	382
LOKIASV2_1322_ESMFold_hypothetical_protein	5toe-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5toe-assembly1.cif.gz_A Pim-1 kinase in complex with a 7-azaindole	0.164	306	223	176	481	5	272	8.155E-12	382
LOKIASV2_1322_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PknB mutant kinase domain in complex with KT5720	0.190	308	211	164	471	1	261	1.598E-11	381
LOKIASV2_1322_ESMFold_hypothetical_protein	2buj-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2buj-assembly2.cif.gz_B Crystal structure of the human Serine-threonine Kinase 16 in complex with staurosporine	0.169	307	231	163	469	4	282	5.978E-12	380
LOKIASV2_1322_ESMFold_hypothetical_protein	4c58-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	4c58-assembly1.cif.gz_A-2 Structure of GAK kinase in complex with nanobody (NbGAK_4)	0.172	314	210	165	478	3	257	2.419E-11	379
LOKIASV2_1322_ESMFold_hypothetical_protein	3ork-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3ork-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 2)	0.189	309	212	163	471	1	262	5.978E-12	375
LOKIASV2_1322_ESMFold_hypothetical_protein	4lm5-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4lm5-assembly1.cif.gz_A Crystal structure of Pim1 in complex with 2-{4-[(3-aminopropyl)amino]quinazolin-2-yl}phenol (resulting from displacement of SKF86002)	0.173	304	215	176	479	4	264	1.773E-11	372
LOKIASV2_1322_ESMFold_hypothetical_protein	3ort-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3ort-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 6)	0.194	301	204	171	471	7	260	3.050E-12	372
LOKIASV2_1322_ESMFold_hypothetical_protein	4x3f-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4x3f-assembly2.cif.gz_B Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	0.215	315	210	162	476	1	268	1.234E-11	372
LOKIASV2_1322_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain	0.181	306	197	163	468	3	243	4.059E-11	371
LOKIASV2_1322_ESMFold_hypothetical_protein	7oai-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7oai-assembly1.cif.gz_A Crystal structure of pseudokinase CASK in complex with PFE-PKIS12	0.177	311	227	169	479	2	278	7.744E-12	371
LOKIASV2_1322_ESMFold_hypothetical_protein	3f61-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3f61-assembly1.cif.gz_A Crystal Structure of M. tuberculosis PknB Leu33Asp/Val222Asp double mutant in complex with ADP	0.187	306	209	166	471	2	259	4.860E-12	369
LOKIASV2_1322_ESMFold_hypothetical_protein	4alu-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4alu-assembly1.cif.gz_A Benzofuropyrimidinone Inhibitors of Pim-1	0.173	312	226	170	481	1	274	1.966E-11	369
LOKIASV2_1322_ESMFold_hypothetical_protein	7t4j-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7t4j-assembly1.cif.gz_B Crystal Structure of EGFR_D770_N771insNPG/V948R in complex with TAK-788	0.167	307	222	176	482	12	278	1.598E-11	369
LOKIASV2_1322_ESMFold_hypothetical_protein	2buj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2buj-assembly1.cif.gz_A Crystal structure of the human Serine-threonine Kinase 16 in complex with staurosporine	0.153	307	239	163	469	3	285	3.133E-11	369
LOKIASV2_1322_ESMFold_hypothetical_protein	2bil-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2bil-assembly1.cif.gz_B The human protein kinase Pim1 in complex with its consensus peptide Pimtide	0.179	306	220	176	481	6	274	9.525E-12	368
LOKIASV2_1322_ESMFold_hypothetical_protein	4wsq-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4wsq-assembly2.cif.gz_B Crystal Structure of Adaptor Protein 2 Associated Kinase (AAK1) in complex with small molecule inhibitor	0.186	305	228	165	469	3	283	3.951E-12	368
LOKIASV2_1322_ESMFold_hypothetical_protein	5xka-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5xka-assembly1.cif.gz_B Crystal structure of M.tuberculosis PknI kinase domain	0.176	315	205	163	477	2	251	6.141E-11	367
LOKIASV2_1322_ESMFold_hypothetical_protein	5n5l-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5n5l-assembly1.cif.gz_A Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and [2-oxo-2-(1H-pyrrol-2-yl)ethyl] 5-bromo-1H-indole-3-carboxylate	0.177	287	202	176	462	6	251	1.598E-11	363
LOKIASV2_1322_ESMFold_hypothetical_protein	4x3f-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4x3f-assembly3.cif.gz_C Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	0.219	301	195	176	476	12	262	2.181E-11	363
LOKIASV2_1322_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.169	302	211	176	477	11	265	8.588E-12	363
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_D Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.219	301	190	176	476	11	254	8.823E-11	362
LOKIASV2_1322_ESMFold_hypothetical_protein	3vbt-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3vbt-assembly1.cif.gz_A Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase needle screening and inhibitor design	0.178	304	215	176	479	4	266	2.825E-11	362
LOKIASV2_1322_ESMFold_hypothetical_protein	5nk3-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5nk3-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1l	0.209	313	214	163	475	2	273	3.562E-12	362
LOKIASV2_1322_ESMFold_hypothetical_protein	1yxs-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1yxs-assembly1.cif.gz_A Crystal Structure of Kinase Pim1 with P123M mutation	0.165	295	222	176	470	6	272	3.133E-11	361
LOKIASV2_1322_ESMFold_hypothetical_protein	4enx-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4enx-assembly1.cif.gz_A Crystal Structure of Pim-1 Kinase in complex with inhibitor (2E,5Z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-nitrobenzylidene)thiazolidin-4-one	0.175	304	217	176	479	2	265	4.274E-11	360
LOKIASV2_1322_ESMFold_hypothetical_protein	4ow8-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	4ow8-assembly1.cif.gz_A-2 Crystal structure of kinase domain of PknA from Mtb	0.211	314	212	163	476	1	270	4.059E-11	360
LOKIASV2_1322_ESMFold_hypothetical_protein	4xli-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4xli-assembly1.cif.gz_A Crystal structure of Abl2/Arg kinase in complex with dasatinib	0.174	302	211	169	470	5	261	6.141E-11	359
LOKIASV2_1322_ESMFold_hypothetical_protein	3umw-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3umw-assembly1.cif.gz_A Crystal structure of Pim1 kinase in complex with inhibitor (Z)-2-[(1H-indazol-3-yl)methylene]-6-methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one	0.180	304	215	176	479	2	264	2.547E-11	357
LOKIASV2_1322_ESMFold_hypothetical_protein	3cxw-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3cxw-assembly1.cif.gz_A Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand I	0.172	304	219	176	479	6	270	2.547E-11	357
LOKIASV2_1322_ESMFold_hypothetical_protein	2iw8-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	2iw8-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	0.206	294	199	176	469	5	256	3.299E-11	356
LOKIASV2_1322_ESMFold_hypothetical_protein	2c3i-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2c3i-assembly1.cif.gz_B CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN I	0.183	287	199	176	462	2	245	3.299E-11	355
LOKIASV2_1322_ESMFold_hypothetical_protein	4eqm-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4eqm-assembly3.cif.gz_C Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	0.211	302	200	168	469	4	257	1.369E-11	353
LOKIASV2_1322_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A Drosophila CaMKII-wt in complex with a fragment of the Eag potassium channel and Mg2+/AMPPN	0.179	295	211	176	470	8	265	4.274E-11	353
LOKIASV2_1322_ESMFold_hypothetical_protein	2g2f-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2g2f-assembly1.cif.gz_A A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	0.171	311	223	169	479	6	275	1.867E-11	352
LOKIASV2_1322_ESMFold_hypothetical_protein	5n4x-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5n4x-assembly1.cif.gz_A Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and fragment like molekule 4,5-dibromothiophene-2-carbohydrazide	0.179	287	201	176	462	6	251	3.854E-11	351
LOKIASV2_1322_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_B Structure of RIP2K(L294F) with bound AMPPCP	0.198	291	208	180	470	18	277	3.659E-11	351
LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_A Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	0.182	314	221	162	475	8	278	3.475E-11	347
LOKIASV2_1322_ESMFold_hypothetical_protein	3orl-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3orl-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 3)	0.187	296	202	176	471	9	257	1.172E-11	345
LOKIASV2_1322_ESMFold_hypothetical_protein	2iw9-assembly1.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	2iw9-assembly1.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.207	292	198	176	467	5	255	1.030E-10	345
LOKIASV2_1322_ESMFold_hypothetical_protein	4eor-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4eor-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor NU6102	0.188	290	206	176	465	5	259	3.299E-11	345
LOKIASV2_1322_ESMFold_hypothetical_protein	3mfu-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3mfu-assembly1.cif.gz_A CASK-4M CaM Kinase Domain, AMPPNP-Mn2+	0.174	310	227	169	478	2	277	3.659E-11	345
LOKIASV2_1322_ESMFold_hypothetical_protein	7xzr-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7xzr-assembly1.cif.gz_A Crystal structure of TNIK-AMPPNP-thiopeptide TP15 complex	0.160	301	239	176	476	14	298	2.547E-11	344
LOKIASV2_1322_ESMFold_hypothetical_protein	4cfm-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4cfm-assembly2.cif.gz_C Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.	0.195	295	202	176	470	5	256	7.554E-11	343
LOKIASV2_1322_ESMFold_hypothetical_protein	4eqm-assembly6.cif.gz_F	LOKIASV2_1322_ESMFold_hypothetical_protein	4eqm-assembly6.cif.gz_F Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	0.221	307	198	163	469	1	255	1.559E-10	343
LOKIASV2_1322_ESMFold_hypothetical_protein	5tur-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5tur-assembly1.cif.gz_A Pim-1 kinase in complex with a 7-azaindole	0.165	295	220	176	470	5	268	8.823E-11	343
LOKIASV2_1322_ESMFold_hypothetical_protein	3kk9-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3kk9-assembly1.cif.gz_A CaMKII Substrate Complex B	0.185	317	222	169	485	1	273	1.030E-10	342
LOKIASV2_1322_ESMFold_hypothetical_protein	4o0s-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4o0s-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	0.165	302	215	167	468	1	259	8.378E-11	341
LOKIASV2_1322_ESMFold_hypothetical_protein	3dj7-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3dj7-assembly1.cif.gz_A Crystal structure of the mouse Aurora-A catalytic domain (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with Compound 130.	0.156	302	214	167	468	1	254	1.642E-10	340
LOKIASV2_1322_ESMFold_hypothetical_protein	3orp-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3orp-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 5)	0.188	302	208	170	471	6	262	2.682E-11	340
LOKIASV2_1322_ESMFold_hypothetical_protein	3bgz-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3bgz-assembly1.cif.gz_A Human Pim-1 kinase in complex with diphenyl indole inhibitor VX3	0.174	304	216	176	479	6	267	8.378E-11	339
LOKIASV2_1322_ESMFold_hypothetical_protein	7vsy-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7vsy-assembly1.cif.gz_A Pim1 with N82K mutation	0.183	304	217	176	479	6	272	1.143E-10	339
LOKIASV2_1322_ESMFold_hypothetical_protein	4x3f-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4x3f-assembly1.cif.gz_A Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	0.194	308	210	169	476	5	265	7.955E-11	339
LOKIASV2_1322_ESMFold_hypothetical_protein	5x1s-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5x1s-assembly1.cif.gz_A PpkA-294 with Amppcp	0.168	304	230	163	466	4	280	2.240E-10	338
LOKIASV2_1322_ESMFold_hypothetical_protein	2owb-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2owb-assembly1.cif.gz_A Structure of the Catalytic Domain of Human Polo-like Kinase 1	0.163	324	234	163	486	1	281	9.785E-11	338
LOKIASV2_1322_ESMFold_hypothetical_protein	3q4t-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3q4t-assembly1.cif.gz_A Crystal structure of Activin receptor type-IIA (ACVR2A) kinase domain in complex with dorsomorphin	0.172	306	250	164	469	1	303	2.547E-11	337
LOKIASV2_1322_ESMFold_hypothetical_protein	5e8v-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5e8v-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A)	0.176	294	240	176	469	5	296	2.547E-11	336
LOKIASV2_1322_ESMFold_hypothetical_protein	2euf-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2euf-assembly1.cif.gz_B X-ray structure of human CDK6-Vcyclin in complex with the inhibitor PD0332991	0.192	292	217	176	467	4	273	5.831E-11	335
LOKIASV2_1322_ESMFold_hypothetical_protein	4b4l-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4b4l-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT	0.189	307	218	164	470	1	270	1.729E-10	335
LOKIASV2_1322_ESMFold_hypothetical_protein	5qtz-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5qtz-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[1-(2,2-DIFLUOROETHYL)-4-(6-METHYLPYRIDIN-2-YL)-1H-IMIDAZOL-5-YL]IMIDAZO[1,2-A]PYRIDINE	0.195	305	241	168	472	3	302	1.867E-11	335
LOKIASV2_1322_ESMFold_hypothetical_protein	8d6d-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8d6d-assembly2.cif.gz_B Crystal Structure of Human Myt1 Kinase domain Bounded with compound 39	0.187	306	205	161	466	14	266	1.918E-10	334
LOKIASV2_1322_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24	0.166	295	234	176	470	3	284	3.854E-11	334
LOKIASV2_1322_ESMFold_hypothetical_protein	5e91-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5e91-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A) IN COMPLEX WITH 3-AMINO-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL] PYRAZINE-2-CARBOXAMIDE	0.173	294	240	176	469	5	295	3.133E-11	334
LOKIASV2_1322_ESMFold_hypothetical_protein	5e8y-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5e8y-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A) IN COMPLEX WITH STAUROSPORINE	0.175	294	242	176	469	5	298	3.854E-11	333
LOKIASV2_1322_ESMFold_hypothetical_protein	5e90-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5e90-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) IN COMPLEX WITH 3-AMINO-6- [4-(2-HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL]PYRAZINE-2-CARBOXAMIDE	0.181	297	240	176	472	9	302	1.172E-11	333
LOKIASV2_1322_ESMFold_hypothetical_protein	3fpm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3fpm-assembly1.cif.gz_A Crystal Structure of a Squarate Inhibitor bound to MAPKAP Kinase-2	0.191	322	215	163	484	6	272	1.598E-11	332
LOKIASV2_1322_ESMFold_hypothetical_protein	3ckx-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3ckx-assembly1.cif.gz_A Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine	0.193	301	219	176	476	5	276	2.419E-11	331
LOKIASV2_1322_ESMFold_hypothetical_protein	6qmo-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6qmo-assembly1.cif.gz_A Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289E and S308A mutations	0.166	308	225	163	470	1	271	4.169E-10	331
LOKIASV2_1322_ESMFold_hypothetical_protein	3dog-assembly1.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	3dog-assembly1.cif.gz_C Structure of Thr 160 phosphorylated CDK2/cyclin A in complex with the inhibitor N-&-N1	0.204	292	197	176	467	5	253	8.378E-11	330
LOKIASV2_1322_ESMFold_hypothetical_protein	8d6c-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8d6c-assembly2.cif.gz_B Crystal Structure of Human Myt1 Kinase domain Bounded with compound 28	0.182	302	209	161	462	17	272	1.642E-10	330
LOKIASV2_1322_ESMFold_hypothetical_protein	5qin-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5qin-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN IN COMPLEX WITH N- {4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2- YL]PYRIDIN-2-YL}ACETAMIDE	0.182	294	237	176	469	5	295	3.299E-11	330
LOKIASV2_1322_ESMFold_hypothetical_protein	4bco-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4bco-assembly2.cif.gz_C Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor	0.188	294	207	176	469	5	260	1.143E-10	328
LOKIASV2_1322_ESMFold_hypothetical_protein	8d6c-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8d6c-assembly1.cif.gz_A Crystal Structure of Human Myt1 Kinase domain Bounded with compound 28	0.173	302	210	161	462	13	267	1.642E-10	328
LOKIASV2_1322_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A CaMKII Substrate Complex A	0.183	314	222	171	484	4	276	8.378E-11	328
LOKIASV2_1322_ESMFold_hypothetical_protein	5o21-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5o21-assembly2.cif.gz_B Crystal structure of WNK3 kinase domain in a monophosphorylated state with chloride bound in the active site	0.158	297	221	166	462	2	265	3.056E-10	327
LOKIASV2_1322_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	0.167	301	219	176	476	7	270	8.823E-11	326
LOKIASV2_1322_ESMFold_hypothetical_protein	1z9x-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1z9x-assembly1.cif.gz_A Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 3 monomers in the asymmetric unit	0.191	307	220	164	470	1	273	1.821E-10	326
LOKIASV2_1322_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B Calcium-Dependent Protein Kinase from Eimeria tenella	0.184	318	225	165	482	12	288	2.825E-11	326
LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_F	LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_F Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	0.185	307	218	162	468	7	274	1.559E-10	325
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7u-assembly1.cif.gz_B-2	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7u-assembly1.cif.gz_B-2 XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010938a	0.192	293	221	176	468	4	277	6.467E-11	325
LOKIASV2_1322_ESMFold_hypothetical_protein	4a4o-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	4a4o-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2-(2-AMINO- PYRIMIDIN-4-YL)-1,5,6,7-TETRAHYDRO-PYRROLOPYRIDIN-4-ONE INHIBITOR	0.167	307	221	164	470	1	266	2.755E-10	325
LOKIASV2_1322_ESMFold_hypothetical_protein	7dv6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7dv6-assembly1.cif.gz_A Discovery of Functionally Selective Transforming Growth Factor beta Type II Receptor (TGF-beta RII) Inhibitors as Anti-Fibrosis Agents	0.171	299	241	176	467	5	303	4.059E-11	325
LOKIASV2_1322_ESMFold_hypothetical_protein	4k18-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4k18-assembly1.cif.gz_A Structure of PIM-1 kinase bound to 5-(4-cyanobenzyl)-N-(4-fluorophenyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxamide	0.172	309	224	176	484	7	277	1.030E-10	324
LOKIASV2_1322_ESMFold_hypothetical_protein	8d6e-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8d6e-assembly1.cif.gz_B Crystal Structure of Human Myt1 Kinase domain Bounded with RP-6306	0.176	307	218	161	467	15	280	4.624E-10	324
LOKIASV2_1322_ESMFold_hypothetical_protein	2iw8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2iw8-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	0.185	294	230	176	469	5	287	1.268E-10	324
LOKIASV2_1322_ESMFold_hypothetical_protein	2a27-assembly4.cif.gz_H	LOKIASV2_1322_ESMFold_hypothetical_protein	2a27-assembly4.cif.gz_H Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 8 monomers in the asymmetric unit	0.191	307	220	164	470	1	273	4.169E-10	324
LOKIASV2_1322_ESMFold_hypothetical_protein	4u45-assembly2.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4u45-assembly2.cif.gz_A MAP4K4 in complex with inhibitor (compound 25)	0.159	302	230	176	477	14	288	1.085E-10	323
LOKIASV2_1322_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B Crystal structure of the autoinhibited form of mouse DAPK2 in complex with ATP	0.192	316	221	169	484	5	279	3.759E-10	323
LOKIASV2_1322_ESMFold_hypothetical_protein	4asx-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4asx-assembly1.cif.gz_A Crystal structure of Activin receptor type-IIA (ACVR2A) kinase domain in complex with dihydro-Bauerine C	0.167	308	252	163	470	4	307	9.785E-11	323
LOKIASV2_1322_ESMFold_hypothetical_protein	6kmh-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6kmh-assembly2.cif.gz_B The crystal structure of CASK/Mint1 complex	0.164	310	230	169	478	2	277	1.406E-10	323
LOKIASV2_1322_ESMFold_hypothetical_protein	4dit-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4dit-assembly1.cif.gz_A Crystal Structure of GSK3beta in complex with a Imidazopyridine inhibitor	0.180	313	230	174	486	20	301	2.297E-11	323
LOKIASV2_1322_ESMFold_hypothetical_protein	8d6e-assembly2.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8d6e-assembly2.cif.gz_A Crystal Structure of Human Myt1 Kinase domain Bounded with RP-6306	0.180	307	210	160	466	14	270	3.570E-10	322
LOKIASV2_1322_ESMFold_hypothetical_protein	6z36-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6z36-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2118	0.177	292	227	176	467	7	283	6.141E-11	322
LOKIASV2_1322_ESMFold_hypothetical_protein	4eok-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4eok-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor NU6102	0.184	292	224	176	467	5	279	7.955E-11	322
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7g-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7g-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035844b	0.179	293	227	176	468	2	279	2.975E-11	321
LOKIASV2_1322_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_C Structure of human phosphorylase kinase, gamma 2	0.173	295	220	176	470	15	281	3.056E-10	321
LOKIASV2_1322_ESMFold_hypothetical_protein	2iw6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2iw6-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.185	291	223	176	466	5	279	1.918E-10	321
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_B-2	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_B-2 XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a	0.181	293	235	176	468	4	291	1.598E-11	321
LOKIASV2_1322_ESMFold_hypothetical_protein	5li1-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5li1-assembly1.cif.gz_A Structure of a Par3-inhibitory peptide bound to PKCiota core kinase domain	0.157	319	240	168	486	3	288	2.020E-10	321
LOKIASV2_1322_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_A Crystal Structure of PKCiota kinase domain	0.164	320	242	167	486	2	291	7.173E-11	321
LOKIASV2_1322_ESMFold_hypothetical_protein	2wtw-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2wtw-assembly1.cif.gz_A Aurora-A Inhibitor Structure (2nd crystal form)	0.162	302	208	169	470	1	249	5.990E-10	320
LOKIASV2_1322_ESMFold_hypothetical_protein	7f3g-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7f3g-assembly1.cif.gz_B Crystal structure of DCLK1 kinase domain in complex with ruxolitinib	0.175	295	211	176	470	8	264	4.391E-10	320
LOKIASV2_1322_ESMFold_hypothetical_protein	4eom-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4eom-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with ATP	0.196	298	208	169	466	2	261	5.128E-10	320
LOKIASV2_1322_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_B Structure of human phosphorylase kinase, gamma 2	0.174	295	217	176	470	15	278	3.389E-10	320
LOKIASV2_1322_ESMFold_hypothetical_protein	4bid-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4bid-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	0.178	304	207	163	466	1	253	1.729E-10	319
LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_E Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	0.183	307	219	162	468	7	275	1.481E-10	319
LOKIASV2_1322_ESMFold_hypothetical_protein	4bgg-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4bgg-assembly3.cif.gz_C Crystal structure of the ACVR1 kinase in complex with LDN-213844	0.184	292	223	176	467	5	278	6.467E-11	319
LOKIASV2_1322_ESMFold_hypothetical_protein	6ra5-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6ra5-assembly1.cif.gz_B Human tnik in complex with compound 9	0.169	301	224	176	476	12	282	2.484E-10	319
LOKIASV2_1322_ESMFold_hypothetical_protein	3r2y-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3r2y-assembly1.cif.gz_A MK2 kinase bound to Compound 1	0.181	321	199	162	482	6	249	1.005E-09	318
LOKIASV2_1322_ESMFold_hypothetical_protein	4i5p-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4i5p-assembly1.cif.gz_A Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain	0.191	296	208	167	462	1	258	3.218E-10	318
LOKIASV2_1322_ESMFold_hypothetical_protein	3d5w-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3d5w-assembly1.cif.gz_A Crystal structure of a phosphorylated Polo-like kinase 1 (Plk1) catalytic domain in complex with ADP.	0.156	300	219	163	462	1	260	3.389E-10	318
LOKIASV2_1322_ESMFold_hypothetical_protein	3q3b-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3q3b-assembly2.cif.gz_B 6-Amino-4-(pyrimidin-4-yl)pyridones: Novel Glycogen Synthase Kinase-3 Inhibitors	0.196	293	219	174	466	20	293	6.141E-11	318
LOKIASV2_1322_ESMFold_hypothetical_protein	2x7g-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2x7g-assembly1.cif.gz_A Structure of human serine-arginine-rich protein-specific kinase 2 (SRPK2) bound to purvalanol B	0.152	342	258	163	467	2	343	7.955E-11	318
LOKIASV2_1322_ESMFold_hypothetical_protein	6cpe-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6cpe-assembly1.cif.gz_A Structure of apo, dephosphorylated Aurora A (122-403) in an active conformation	0.152	300	212	169	468	2	252	7.760E-10	317
LOKIASV2_1322_ESMFold_hypothetical_protein	2wot-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2wot-assembly1.cif.gz_A ALK5 IN COMPLEX WITH 4-((5,6-dimethyl-2-(2-pyridyl)-3-pyridyl)oxy)-N-(3,4,5-trimethoxyphenyl)pyridin-2-amine	0.194	297	236	176	472	8	301	2.297E-11	317
LOKIASV2_1322_ESMFold_hypothetical_protein	3d15-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3d15-assembly1.cif.gz_A Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with 1-(3-chloro-phenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)- ethyl]-thiazol-2-yl}-urea [SNS-314]	0.151	302	214	167	468	1	253	4.169E-10	316
LOKIASV2_1322_ESMFold_hypothetical_protein	5a4e-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	5a4e-assembly3.cif.gz_C DYRK1A in complex with methoxy benzothiazole fragment	0.188	294	197	163	456	16	258	2.902E-10	316
LOKIASV2_1322_ESMFold_hypothetical_protein	6bqq-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6bqq-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with BI2526	0.155	299	226	169	467	2	270	5.990E-10	316
LOKIASV2_1322_ESMFold_hypothetical_protein	4f0f-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4f0f-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain bound to AppCp from D. discoideum	0.168	294	221	176	469	10	276	3.959E-10	316
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7g-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7g-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035844b	0.179	293	227	176	468	7	283	1.030E-10	316
LOKIASV2_1322_ESMFold_hypothetical_protein	3eid-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3eid-assembly1.cif.gz_A CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	0.178	291	224	176	466	4	276	1.821E-10	316
LOKIASV2_1322_ESMFold_hypothetical_protein	6ylc-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6ylc-assembly2.cif.gz_B Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	0.193	298	229	176	473	5	289	9.291E-11	316
LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_B Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	0.187	302	211	162	463	7	267	1.406E-10	315
LOKIASV2_1322_ESMFold_hypothetical_protein	3l1s-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3l1s-assembly2.cif.gz_B 3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3	0.194	290	213	174	463	19	283	1.085E-10	315
LOKIASV2_1322_ESMFold_hypothetical_protein	8edh-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	8edh-assembly2.cif.gz_C Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	0.155	290	207	176	465	11	256	6.996E-10	314
LOKIASV2_1322_ESMFold_hypothetical_protein	6szm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6szm-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2009	0.187	292	226	176	467	7	285	3.475E-11	314
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly9.cif.gz_I	LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly9.cif.gz_I Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	0.186	323	217	162	484	7	273	2.127E-10	314
LOKIASV2_1322_ESMFold_hypothetical_protein	6zgc-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6zgc-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	0.179	294	236	176	469	4	291	3.299E-11	314
LOKIASV2_1322_ESMFold_hypothetical_protein	2jld-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2jld-assembly1.cif.gz_B Extremely Tight Binding of Ruthenium Complex to Glycogen Synthase Kinase 3	0.195	290	225	174	463	20	300	4.992E-11	314
LOKIASV2_1322_ESMFold_hypothetical_protein	4fg7-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4fg7-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-293 in complex with ATP	0.161	295	198	176	470	12	248	2.075E-09	313
LOKIASV2_1322_ESMFold_hypothetical_protein	7m5z-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7m5z-assembly1.cif.gz_A Crystal Structure of the MerTK Kinase Domain in Complex with Inhibitor MIPS15692	0.146	295	212	176	470	11	259	1.030E-10	313
LOKIASV2_1322_ESMFold_hypothetical_protein	4eol-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4eol-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	0.179	294	229	176	469	5	284	1.559E-10	313
LOKIASV2_1322_ESMFold_hypothetical_protein	3tzm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3tzm-assembly1.cif.gz_A TGF-beta Receptor type 1 in complex with SB431542	0.194	294	232	176	469	6	294	4.740E-11	313
LOKIASV2_1322_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_B GSK-3 Beta complexed with AMP-PNP	0.180	296	228	174	469	20	298	7.554E-11	313
LOKIASV2_1322_ESMFold_hypothetical_protein	6s73-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6s73-assembly3.cif.gz_C Crystal structure of Nek7 SRS mutant bound to compound 51	0.166	295	205	176	470	9	255	9.545E-10	312
LOKIASV2_1322_ESMFold_hypothetical_protein	6nzp-assembly3.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6nzp-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE	0.163	292	208	176	467	10	259	6.308E-10	312
LOKIASV2_1322_ESMFold_hypothetical_protein	3gok-assembly1.cif.gz_F	LOKIASV2_1322_ESMFold_hypothetical_protein	3gok-assembly1.cif.gz_F Binding site mapping of protein ligands	0.176	323	227	162	484	6	281	1.085E-10	312
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7v-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7v-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010942a	0.180	292	233	176	467	4	288	5.537E-11	312
LOKIASV2_1322_ESMFold_hypothetical_protein	2vgo-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2vgo-assembly2.cif.gz_B Crystal structure of Aurora B kinase in complex with Reversine inhibitor	0.177	308	214	163	470	3	263	9.785E-11	311
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7z-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7z-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with NU074488b	0.184	292	226	176	467	7	284	1.085E-10	311
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_F	LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_F MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	0.190	320	218	162	481	8	277	9.291E-11	311
LOKIASV2_1322_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A Inhibitory scaffolding of the ancient MAPK, ERK7	0.163	304	252	176	477	10	313	6.630E-12	311
LOKIASV2_1322_ESMFold_hypothetical_protein	4mq1-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4mq1-assembly3.cif.gz_C The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.179	311	250	163	467	15	325	2.755E-10	311
LOKIASV2_1322_ESMFold_hypothetical_protein	4csv-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4csv-assembly1.cif.gz_A Tyrosine kinase AS - a common ancestor of Src and Abl bound to Gleevec	0.168	292	192	176	467	9	240	1.371E-09	310
LOKIASV2_1322_ESMFold_hypothetical_protein	5v19-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5v19-assembly2.cif.gz_B Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	0.177	301	207	163	463	1	253	5.990E-10	310
LOKIASV2_1322_ESMFold_hypothetical_protein	7ako-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7ako-assembly1.cif.gz_A Crystal structure of CHK1 kinase domain in complex with a CLASPIN phosphopeptide	0.185	296	209	176	471	8	265	4.624E-10	310
LOKIASV2_1322_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E Crystal structure of CASK-CaMK in complex with Mint1-CID	0.176	309	227	169	477	1	277	2.902E-10	310
LOKIASV2_1322_ESMFold_hypothetical_protein	3q3b-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3q3b-assembly1.cif.gz_A 6-Amino-4-(pyrimidin-4-yl)pyridones: Novel Glycogen Synthase Kinase-3 Inhibitors	0.178	296	231	174	469	20	301	1.085E-10	310
LOKIASV2_1322_ESMFold_hypothetical_protein	1how-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1how-assembly1.cif.gz_A THE X-RAY CRYSTAL STRUCTURE OF SKY1P, AN SR PROTEIN KINASE IN YEAST	0.159	327	270	160	481	2	328	2.359E-10	310
LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_F	LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_F Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.166	301	219	167	467	1	264	1.776E-09	309
LOKIASV2_1322_ESMFold_hypothetical_protein	2pzy-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2pzy-assembly2.cif.gz_B Structure of MK2 Complexed with Compound 76	0.192	319	215	163	481	6	272	6.308E-10	309
LOKIASV2_1322_ESMFold_hypothetical_protein	5vcw-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5vcw-assembly2.cif.gz_B CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Pelitinib	0.183	306	211	161	466	19	277	5.990E-10	309
LOKIASV2_1322_ESMFold_hypothetical_protein	2x7f-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	2x7f-assembly3.cif.gz_C Crystal structure of the kinase domain of human Traf2- and Nck- interacting Kinase with Wee1Chk1 inhibitor	0.157	301	227	176	476	12	281	1.481E-10	309
LOKIASV2_1322_ESMFold_hypothetical_protein	5vcz-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5vcz-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Bosutinib isomer	0.186	306	210	161	466	28	286	4.391E-10	309
LOKIASV2_1322_ESMFold_hypothetical_protein	6zgc-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6zgc-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	0.183	300	239	169	468	3	295	4.501E-11	309
LOKIASV2_1322_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10-ATP-gamma-S Complex	0.172	297	239	176	472	6	295	6.141E-11	309
LOKIASV2_1322_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I	LOKIASV2_1322_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I crystal structure of P-TEFb complex with AFF4 and Tat	0.180	295	239	176	470	12	303	1.481E-10	309
LOKIASV2_1322_ESMFold_hypothetical_protein	6lnm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6lnm-assembly1.cif.gz_A Crystal structure of CASK-CaMK in complex with Mint1-CID	0.173	307	227	169	475	1	275	3.218E-10	309
LOKIASV2_1322_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_A crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	0.180	290	226	174	463	20	296	1.918E-10	309
LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_D Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.167	295	190	169	463	2	230	6.825E-09	308
LOKIASV2_1322_ESMFold_hypothetical_protein	4yzn-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4yzn-assembly1.cif.gz_A Humanized Roco4 bound to Compound 19	0.181	307	218	163	469	3	269	6.643E-10	308
LOKIASV2_1322_ESMFold_hypothetical_protein	3she-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3she-assembly1.cif.gz_A Novel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series	0.163	315	193	165	479	1	232	2.484E-10	308
LOKIASV2_1322_ESMFold_hypothetical_protein	8tuc-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8tuc-assembly1.cif.gz_A Unphosphorylated CaMKK2 in complex with CC-8977	0.163	298	229	169	466	2	275	7.760E-10	308
LOKIASV2_1322_ESMFold_hypothetical_protein	3db6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3db6-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 902	0.158	300	220	163	462	1	262	6.308E-10	308
LOKIASV2_1322_ESMFold_hypothetical_protein	4bic-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4bic-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	0.172	305	214	163	467	1	259	7.368E-10	307
LOKIASV2_1322_ESMFold_hypothetical_protein	6t6d-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6t6d-assembly4.cif.gz_D Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	0.183	300	231	169	468	1	284	1.918E-10	307
LOKIASV2_1322_ESMFold_hypothetical_protein	5s87-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5s87-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010953a	0.185	293	231	176	468	4	288	7.955E-11	307
LOKIASV2_1322_ESMFold_hypothetical_protein	2iw9-assembly2.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2iw9-assembly2.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.187	291	222	176	466	5	278	3.959E-10	307
LOKIASV2_1322_ESMFold_hypothetical_protein	1vjy-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1vjy-assembly1.cif.gz_A Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptor	0.200	298	232	176	473	5	295	1.030E-10	307
LOKIASV2_1322_ESMFold_hypothetical_protein	1ny3-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1ny3-assembly1.cif.gz_A Crystal structure of ADP bound to MAP KAP kinase 2	0.186	295	197	176	470	18	260	5.688E-10	306
LOKIASV2_1322_ESMFold_hypothetical_protein	6cmj-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6cmj-assembly2.cif.gz_B Human CAMKK2 with GSK650393	0.150	293	228	176	468	5	273	6.308E-10	306
LOKIASV2_1322_ESMFold_hypothetical_protein	3hmm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3hmm-assembly1.cif.gz_A Structure of Alk5 + GW855857	0.191	295	231	176	470	5	291	1.143E-10	306
LOKIASV2_1322_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form II	0.158	326	265	155	480	10	325	5.537E-11	306
LOKIASV2_1322_ESMFold_hypothetical_protein	2jld-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2jld-assembly1.cif.gz_A Extremely Tight Binding of Ruthenium Complex to Glycogen Synthase Kinase 3	0.177	290	230	174	463	20	299	1.729E-10	306
LOKIASV2_1322_ESMFold_hypothetical_protein	3efl-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3efl-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with motesanib	0.160	295	208	176	470	14	262	1.005E-09	305
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7t-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7t-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010926a	0.172	292	227	176	467	7	281	1.559E-10	305
LOKIASV2_1322_ESMFold_hypothetical_protein	5s78-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5s78-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010934a	0.171	292	228	176	467	7	282	1.821E-10	305
LOKIASV2_1322_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	0.132	319	231	152	470	7	273	4.391E-10	305
LOKIASV2_1322_ESMFold_hypothetical_protein	5s76-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5s76-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010916a	0.182	292	233	176	467	4	289	1.268E-10	305
LOKIASV2_1322_ESMFold_hypothetical_protein	6t6d-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6t6d-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	0.171	292	235	176	467	5	289	2.240E-10	305
LOKIASV2_1322_ESMFold_hypothetical_protein	4eos-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4eos-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor RO3306	0.181	291	224	176	466	7	281	3.218E-10	305
LOKIASV2_1322_ESMFold_hypothetical_protein	6s11-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6s11-assembly2.cif.gz_B Crystal Structure of DYRK1A with small molecule inhibitor	0.167	312	253	163	467	14	325	1.559E-10	305
LOKIASV2_1322_ESMFold_hypothetical_protein	2vx3-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	2vx3-assembly3.cif.gz_C Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1A	0.177	320	250	163	467	15	334	1.642E-10	305
LOKIASV2_1322_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A Crystal structure of the Kinase domain of WNK1	0.158	287	213	176	462	11	264	4.169E-10	304
LOKIASV2_1322_ESMFold_hypothetical_protein	4j7b-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4j7b-assembly2.cif.gz_D Crystal structure of polo-like kinase 1	0.155	304	215	163	466	5	260	3.306E-09	304
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7l-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7l-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010943a	0.179	299	232	169	467	1	283	2.240E-10	304
LOKIASV2_1322_ESMFold_hypothetical_protein	8ak2-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8ak2-assembly1.cif.gz_A Drosophila melanogaster UNC89 Protein Kinase Domain 1 (apo)	0.148	300	220	176	475	3	261	1.115E-09	304
LOKIASV2_1322_ESMFold_hypothetical_protein	6gue-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6gue-assembly2.cif.gz_C CDK2/CyclinA in complex with AZD5438	0.186	295	222	176	470	5	278	5.688E-10	304
LOKIASV2_1322_ESMFold_hypothetical_protein	5oy6-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	5oy6-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with cyclical inhibitor OD36.	0.179	293	234	176	468	5	290	9.291E-11	304
LOKIASV2_1322_ESMFold_hypothetical_protein	5li9-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5li9-assembly1.cif.gz_A Structure of a nucleotide-bound form of PKCiota core kinase domain	0.152	319	240	167	485	1	284	1.642E-10	304
LOKIASV2_1322_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_A GSK-3 Beta complexed with AMP-PNP	0.183	290	222	174	463	20	292	1.559E-10	304
LOKIASV2_1322_ESMFold_hypothetical_protein	1j1b-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1j1b-assembly1.cif.gz_B Binary complex structure of human tau protein kinase I with AMPPNP	0.167	313	250	163	463	1	313	6.141E-11	304
LOKIASV2_1322_ESMFold_hypothetical_protein	5s82-assembly1.cif.gz_B-2	LOKIASV2_1322_ESMFold_hypothetical_protein	5s82-assembly1.cif.gz_B-2 XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035128c	0.185	293	227	176	468	4	282	2.359E-10	303
LOKIASV2_1322_ESMFold_hypothetical_protein	7akb-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7akb-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 56	0.167	322	255	161	467	6	327	1.559E-10	303
LOKIASV2_1322_ESMFold_hypothetical_protein	6jkm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6jkm-assembly1.cif.gz_A Crystal structure of BubR1 kinase domain	0.187	329	249	152	480	17	323	1.406E-10	303
LOKIASV2_1322_ESMFold_hypothetical_protein	3f7z-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3f7z-assembly2.cif.gz_B X-ray Co-Crystal Structure of Glycogen Synthase Kinase 3beta in Complex with an Inhibitor	0.185	301	237	163	463	1	292	2.127E-10	303
LOKIASV2_1322_ESMFold_hypothetical_protein	4nm0-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4nm0-assembly1.cif.gz_A Crystal structure of peptide inhibitor-free GSK-3/Axin complex	0.174	290	232	174	463	26	307	3.959E-10	303
LOKIASV2_1322_ESMFold_hypothetical_protein	5wdy-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5wdy-assembly2.cif.gz_B Crystal structure of WNK1 in complex with 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine (compound 6)	0.152	297	209	166	462	5	252	4.624E-10	302
LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_C Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	0.183	307	217	162	468	8	274	7.368E-10	302
LOKIASV2_1322_ESMFold_hypothetical_protein	5uyj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5uyj-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B	0.152	298	234	169	466	2	278	1.005E-09	302
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly6.cif.gz_F	LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly6.cif.gz_F Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	0.187	324	215	162	485	7	272	1.335E-10	302
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7i-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7i-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010928a	0.188	292	233	176	467	4	291	7.554E-11	302
LOKIASV2_1322_ESMFold_hypothetical_protein	7z5n-assembly8.cif.gz_H	LOKIASV2_1322_ESMFold_hypothetical_protein	7z5n-assembly8.cif.gz_H Crystal structure of DYRK1A in complex with CX-4945	0.180	305	235	163	467	15	302	4.624E-10	302
LOKIASV2_1322_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A Crystal structure of CK2a1 H160A with hematein	0.157	325	270	152	476	10	330	2.127E-10	302
LOKIASV2_1322_ESMFold_hypothetical_protein	4o0u-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4o0u-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	0.151	300	212	169	468	3	253	9.063E-10	301
LOKIASV2_1322_ESMFold_hypothetical_protein	6cd6-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6cd6-assembly3.cif.gz_C Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.156	292	219	176	467	5	264	2.423E-09	301
LOKIASV2_1322_ESMFold_hypothetical_protein	1dm2-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1dm2-assembly1.cif.gz_A HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE	0.169	295	214	176	470	4	261	8.172E-10	301
LOKIASV2_1322_ESMFold_hypothetical_protein	6bql-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6bql-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with TAE-226	0.149	299	234	169	467	2	277	5.401E-10	301
LOKIASV2_1322_ESMFold_hypothetical_protein	6t6d-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6t6d-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	0.178	302	225	167	468	3	277	8.378E-11	301
LOKIASV2_1322_ESMFold_hypothetical_protein	4b6l-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4b6l-assembly1.cif.gz_A Discovery of Oral Polo-Like Kinase (PLK) Inhibitors with Enhanced Selectivity Profile using Residue Targeted Drug Design	0.179	302	217	167	468	1	265	1.059E-09	301
LOKIASV2_1322_ESMFold_hypothetical_protein	5uy6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5uy6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B	0.151	299	237	169	467	2	281	1.521E-09	301
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7w-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7w-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with HM000007h	0.173	292	227	176	467	7	281	1.729E-10	301
LOKIASV2_1322_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	0.178	297	236	176	472	6	293	1.406E-10	301
LOKIASV2_1322_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A Crystal structure of Arabidopsis thaliana CK2-alpha-1 in complex with TTP-22	0.167	301	247	176	476	31	328	1.481E-10	301
LOKIASV2_1322_ESMFold_hypothetical_protein	3anr-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3anr-assembly2.cif.gz_B human DYRK1A/harmine complex	0.168	324	255	163	470	17	340	1.335E-10	301
LOKIASV2_1322_ESMFold_hypothetical_protein	6c83-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6c83-assembly1.cif.gz_B Structure of Aurora A (122-403) bound to inhibitory Monobody Mb2 and AMPPCP	0.160	302	201	169	470	2	241	6.643E-10	300
LOKIASV2_1322_ESMFold_hypothetical_protein	6brc-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6brc-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with AP26113-analog (ALK-IN-1)	0.149	299	223	169	467	2	264	1.236E-09	300
LOKIASV2_1322_ESMFold_hypothetical_protein	4j7b-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4j7b-assembly1.cif.gz_A Crystal structure of polo-like kinase 1	0.165	316	218	161	476	5	266	2.688E-09	300
LOKIASV2_1322_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	0.156	294	222	169	462	1	264	2.981E-09	300
LOKIASV2_1322_ESMFold_hypothetical_protein	4eop-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4eop-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with the inhibitor RO3306	0.192	292	225	176	467	5	283	6.308E-10	300
LOKIASV2_1322_ESMFold_hypothetical_protein	7aj8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7aj8-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 25	0.167	326	256	163	470	2	327	2.359E-10	300
LOKIASV2_1322_ESMFold_hypothetical_protein	3zrm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3zrm-assembly1.cif.gz_A Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors	0.167	300	239	174	473	19	306	1.143E-10	300
LOKIASV2_1322_ESMFold_hypothetical_protein	3say-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3say-assembly1.cif.gz_A Crystal structure of human glycogen synthase kinase 3 beta (GSK3b) in complex with inhibitor 142	0.180	290	229	174	463	20	299	2.240E-10	300
LOKIASV2_1322_ESMFold_hypothetical_protein	1q97-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1q97-assembly2.cif.gz_B The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	0.143	343	275	163	484	3	345	2.902E-10	300
LOKIASV2_1322_ESMFold_hypothetical_protein	6s73-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6s73-assembly4.cif.gz_D Crystal structure of Nek7 SRS mutant bound to compound 51	0.163	295	203	176	470	12	255	1.970E-09	299
LOKIASV2_1322_ESMFold_hypothetical_protein	3orz-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	3orz-assembly3.cif.gz_C PDK1 mutant bound to allosteric disulfide fragment activator 2A2	0.173	313	222	163	475	1	270	1.444E-09	299
LOKIASV2_1322_ESMFold_hypothetical_protein	4hjo-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4hjo-assembly1.cif.gz_A Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinib	0.187	314	222	169	482	5	278	1.970E-09	299
LOKIASV2_1322_ESMFold_hypothetical_protein	1ql6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1ql6-assembly1.cif.gz_A THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES	0.168	295	222	176	470	9	276	8.172E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	5s85-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5s85-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000884c	0.172	293	226	176	468	7	280	2.902E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a	0.181	292	225	176	467	7	282	2.127E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_A Crystal Structure of Cdk-related protein kinase 6 (PK6) from Plasmodium falciparum in complex with inhibitor TCMDC-123995	0.170	299	228	169	467	5	280	5.990E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	6zgc-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6zgc-assembly4.cif.gz_D Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	0.181	293	233	176	468	6	290	1.030E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	4eol-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4eol-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	0.180	299	232	169	467	2	285	1.918E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	5oxg-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	5oxg-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854	0.187	294	236	176	469	10	300	1.204E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	7a4w-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7a4w-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 3	0.160	324	258	163	470	14	337	1.642E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	6b8j-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6b8j-assembly1.cif.gz_A Co-structure of human glycogen synthase kinase beta with a selective (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine inhibitor	0.183	297	230	174	470	18	300	1.918E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	1o9u-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	1o9u-assembly1.cif.gz_A-2 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE	0.193	293	227	174	466	20	301	1.406E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	5air-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5air-assembly1.cif.gz_A Structural analysis of mouse GSK3beta fused with LRP6 peptide.	0.182	290	228	174	463	26	305	4.391E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	1q99-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1q99-assembly1.cif.gz_A Crystal structure of the Saccharomyces cerevisiae SR protein kinsae, Sky1p, complexed with the non-hydrolyzable ATP analogue, AMP-PNP	0.151	320	258	163	467	5	324	2.484E-10	299
LOKIASV2_1322_ESMFold_hypothetical_protein	8jmx-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8jmx-assembly1.cif.gz_A The crystal structure of human aurka kinase domain in complex with AURKA-A2	0.153	302	204	169	470	2	243	3.306E-09	298
LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_A Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.176	299	212	169	467	2	259	4.750E-09	298
LOKIASV2_1322_ESMFold_hypothetical_protein	3r30-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3r30-assembly1.cif.gz_A MK2 kinase bound to Compound 2	0.185	321	202	162	482	6	254	2.075E-09	298
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly7.cif.gz_G	LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly7.cif.gz_G Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	0.191	320	214	162	481	7	272	2.616E-10	298
LOKIASV2_1322_ESMFold_hypothetical_protein	4mq2-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4mq2-assembly4.cif.gz_D The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.177	311	250	163	467	15	325	2.359E-10	298
LOKIASV2_1322_ESMFold_hypothetical_protein	3anq-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	3anq-assembly4.cif.gz_D human DYRK1A/inhibitor complex	0.166	318	254	163	467	14	331	1.406E-10	298
LOKIASV2_1322_ESMFold_hypothetical_protein	4mq2-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4mq2-assembly2.cif.gz_B The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.167	320	253	163	467	15	334	1.729E-10	298
LOKIASV2_1322_ESMFold_hypothetical_protein	6eis-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6eis-assembly3.cif.gz_C DYRK1A in complex with JWC-055	0.176	323	250	163	467	15	337	1.481E-10	298
LOKIASV2_1322_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_B crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	0.187	296	230	174	469	20	303	1.268E-10	298
LOKIASV2_1322_ESMFold_hypothetical_protein	4j1r-assembly6.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4j1r-assembly6.cif.gz_C Crystal Structure of GSK3b in complex with inhibitor 15R	0.166	290	231	174	463	19	296	2.902E-10	298
LOKIASV2_1322_ESMFold_hypothetical_protein	4bid-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4bid-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.190	304	207	163	466	1	256	2.616E-10	297
LOKIASV2_1322_ESMFold_hypothetical_protein	6e2n-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6e2n-assembly1.cif.gz_A ASK1 kinase domain complex with inhibitor	0.193	304	207	163	466	1	258	9.545E-10	297
LOKIASV2_1322_ESMFold_hypothetical_protein	1zys-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1zys-assembly1.cif.gz_A Co-crystal structure of Checkpoint Kinase Chk1 with a pyrrolo-pyridine inhibitor	0.187	287	203	176	462	7	257	1.236E-09	297
LOKIASV2_1322_ESMFold_hypothetical_protein	5ax9-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5ax9-assembly2.cif.gz_B Crystal structure of the kinase domain of human TRAF2 and NCK-interacting protein kinase in complex with compund 9	0.173	298	215	176	473	13	273	1.821E-10	297
LOKIASV2_1322_ESMFold_hypothetical_protein	1y91-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1y91-assembly1.cif.gz_A Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor	0.192	294	218	176	469	4	274	6.643E-10	297
LOKIASV2_1322_ESMFold_hypothetical_protein	8ahi-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8ahi-assembly1.cif.gz_A PAC-FragmentDEL: Photoactivated covalent capture of DNA encoded fragments for hit discovery	0.130	288	216	180	467	26	274	2.552E-09	297
LOKIASV2_1322_ESMFold_hypothetical_protein	7a52-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7a52-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 6	0.172	321	252	163	467	8	328	6.996E-10	297
LOKIASV2_1322_ESMFold_hypothetical_protein	4f1o-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4f1o-assembly1.cif.gz_A Crystal Structure of the L1180T mutant Roco4 Kinase Domain from D. discoideum bound to AppCp	0.165	294	222	176	469	10	276	1.687E-09	296
LOKIASV2_1322_ESMFold_hypothetical_protein	5s8b-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5s8b-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010960a	0.168	299	233	169	467	1	281	1.821E-10	296
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7o-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5s7o-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM007391c	0.185	299	231	169	467	1	284	2.755E-10	296
LOKIASV2_1322_ESMFold_hypothetical_protein	6srh-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6srh-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2117	0.175	299	234	169	467	1	285	1.642E-10	296
LOKIASV2_1322_ESMFold_hypothetical_protein	1oi9-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1oi9-assembly1.cif.gz_A Structure of human Thr160-phospho CDK2/cyclin A complexed with a 6-cyclohexylmethyloxy-2-anilino-purine inhibitor	0.176	288	227	176	463	5	281	9.063E-10	296
LOKIASV2_1322_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D Human CSNK2A2 bound to ERB-041	0.169	301	239	176	476	33	321	3.218E-10	296
LOKIASV2_1322_ESMFold_hypothetical_protein	6ej4-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6ej4-assembly3.cif.gz_C DYRK1A in complex with XMD7-112	0.164	317	257	163	470	15	331	1.406E-10	296
LOKIASV2_1322_ESMFold_hypothetical_protein	5a54-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	5a54-assembly4.cif.gz_D DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT	0.166	316	254	163	467	16	331	9.291E-11	296
LOKIASV2_1322_ESMFold_hypothetical_protein	1h8f-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1h8f-assembly1.cif.gz_B Glycogen Synthase Kinase 3 beta.	0.176	293	232	174	466	20	301	5.990E-10	296
LOKIASV2_1322_ESMFold_hypothetical_protein	4yzb-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4yzb-assembly1.cif.gz_A CDPK1 from Eimeria tenella in complex with inhibitor UW1521	0.178	301	216	167	467	13	276	6.996E-10	296
LOKIASV2_1322_ESMFold_hypothetical_protein	5fp6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5fp6-assembly1.cif.gz_A Structure of cyclin-dependent kinase 2 with small-molecule ligand 3-(4,7-dichloro-1H-indol-3-yl)prop-2-yn-1-ol (AT17833) in an alternate binding site.	0.179	294	218	176	469	4	270	6.308E-10	295
LOKIASV2_1322_ESMFold_hypothetical_protein	3gxl-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3gxl-assembly1.cif.gz_A ALK-5 kinase complex with GW857175	0.191	295	225	176	470	5	283	2.616E-10	295
LOKIASV2_1322_ESMFold_hypothetical_protein	3d5u-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3d5u-assembly1.cif.gz_A Crystal structure of a wildtype Polo-like kinase 1 (Plk1) catalytic domain.	0.179	300	215	163	462	1	263	1.236E-09	295
LOKIASV2_1322_ESMFold_hypothetical_protein	4mq1-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4mq1-assembly4.cif.gz_D The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.168	319	253	163	467	15	333	2.359E-10	295
LOKIASV2_1322_ESMFold_hypothetical_protein	6s1i-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6s1i-assembly4.cif.gz_D Crystal Structure of DYRK1A with small molecule inhibitor	0.166	326	254	163	467	15	340	2.240E-10	295
LOKIASV2_1322_ESMFold_hypothetical_protein	6ae3-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6ae3-assembly1.cif.gz_A Crystal structure of GSK3beta complexed with Morin	0.178	297	231	174	470	19	300	4.624E-10	295
LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly2.cif.gz_B Crystal structure of SRPK2 in complex with compound 1	0.154	339	259	163	469	4	342	1.918E-10	295
LOKIASV2_1322_ESMFold_hypothetical_protein	5eyk-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5eyk-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH BI 847325	0.146	295	209	176	470	6	251	1.918E-10	294
LOKIASV2_1322_ESMFold_hypothetical_protein	4m66-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4m66-assembly2.cif.gz_B Crystal structure of the mouse RIP3 kinase domain	0.145	302	207	176	477	9	251	5.843E-09	294
LOKIASV2_1322_ESMFold_hypothetical_protein	2btr-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2btr-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873	0.174	292	211	176	467	4	259	1.776E-09	294
LOKIASV2_1322_ESMFold_hypothetical_protein	2pvl-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2pvl-assembly1.cif.gz_A Structure-Based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase CK2	0.161	314	251	163	476	26	325	4.624E-10	294
LOKIASV2_1322_ESMFold_hypothetical_protein	7z5n-assembly5.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	7z5n-assembly5.cif.gz_E Crystal structure of DYRK1A in complex with CX-4945	0.177	321	250	163	467	15	335	3.389E-10	294
LOKIASV2_1322_ESMFold_hypothetical_protein	7sxh-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7sxh-assembly1.cif.gz_A BIO-8546 bound GSK3beta-axin complex	0.193	290	222	174	463	18	293	2.484E-10	294
LOKIASV2_1322_ESMFold_hypothetical_protein	6s1i-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6s1i-assembly3.cif.gz_C Crystal Structure of DYRK1A with small molecule inhibitor	0.172	325	252	163	467	15	339	3.389E-10	294
LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly3.cif.gz_C Crystal structure of SRPK2 in complex with compound 1	0.156	338	258	163	469	4	341	1.335E-10	294
LOKIASV2_1322_ESMFold_hypothetical_protein	1uv5-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	1uv5-assembly1.cif.gz_A-2 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'-OXIME	0.171	290	233	174	463	20	301	5.128E-10	294
LOKIASV2_1322_ESMFold_hypothetical_protein	4nm5-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4nm5-assembly1.cif.gz_A Crystal structure of GSK-3/Axin complex bound to phosphorylated Wnt receptor LRP6 c-motif	0.168	317	251	167	469	4	320	6.467E-11	294
LOKIASV2_1322_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	0.159	297	214	166	462	5	259	1.687E-09	293
LOKIASV2_1322_ESMFold_hypothetical_protein	1r1w-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1r1w-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET	0.152	295	204	176	470	27	268	9.545E-10	293
LOKIASV2_1322_ESMFold_hypothetical_protein	6ra5-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6ra5-assembly1.cif.gz_A Human tnik in complex with compound 9	0.156	298	235	176	473	14	292	1.236E-09	293
LOKIASV2_1322_ESMFold_hypothetical_protein	5acb-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	5acb-assembly2.cif.gz_D Crystal Structure of the Human Cdk12-Cyclink Complex	0.166	292	239	176	467	10	297	2.755E-10	293
LOKIASV2_1322_ESMFold_hypothetical_protein	6eiq-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6eiq-assembly3.cif.gz_C DYRK1A in complex with XMD14-124	0.162	315	255	163	467	15	329	1.481E-10	293
LOKIASV2_1322_ESMFold_hypothetical_protein	6ae3-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6ae3-assembly1.cif.gz_B Crystal structure of GSK3beta complexed with Morin	0.185	306	236	174	479	19	308	3.570E-10	293
LOKIASV2_1322_ESMFold_hypothetical_protein	6cd6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6cd6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.165	291	215	176	466	4	262	3.667E-09	292
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly11.cif.gz_K	LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly11.cif.gz_K Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	0.170	316	203	162	477	5	250	1.115E-09	292
LOKIASV2_1322_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.180	288	218	176	463	3	269	1.236E-09	292
LOKIASV2_1322_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	0.158	320	234	162	481	11	289	5.128E-10	292
LOKIASV2_1322_ESMFold_hypothetical_protein	3u87-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3u87-assembly1.cif.gz_A Structure of a chimeric construct of human CK2alpha and human CK2alpha' in complex with a non-hydrolysable ATP-analogue	0.165	301	242	176	476	38	328	6.308E-10	292
LOKIASV2_1322_ESMFold_hypothetical_protein	7ake-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7ake-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 58	0.168	319	253	163	467	9	327	2.020E-10	292
LOKIASV2_1322_ESMFold_hypothetical_protein	4mq2-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4mq2-assembly1.cif.gz_A The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.173	325	251	163	467	14	338	2.240E-10	292
LOKIASV2_1322_ESMFold_hypothetical_protein	3m1s-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3m1s-assembly1.cif.gz_A Structure of Ruthenium Half-Sandwich Complex Bound to Glycogen Synthase Kinase 3	0.183	296	234	174	469	20	306	1.642E-10	292
LOKIASV2_1322_ESMFold_hypothetical_protein	2c6e-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2c6e-assembly1.cif.gz_A Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	0.165	300	205	169	468	2	247	3.139E-09	291
LOKIASV2_1322_ESMFold_hypothetical_protein	6s73-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6s73-assembly2.cif.gz_B Crystal structure of Nek7 SRS mutant bound to compound 51	0.175	295	205	176	470	15	264	1.776E-09	291
LOKIASV2_1322_ESMFold_hypothetical_protein	3f3z-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	3f3z-assembly1.cif.gz_A-2 Crystal structure of Cryptosporidium parvum calcium dependent protein kinase cgd7_1840 in presence of indirubin E804	0.165	302	219	176	477	6	268	3.482E-09	291
LOKIASV2_1322_ESMFold_hypothetical_protein	1ckp-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1ckp-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B	0.171	292	215	176	467	4	263	1.302E-09	291
LOKIASV2_1322_ESMFold_hypothetical_protein	3f5x-assembly1.cif.gz_A-3	LOKIASV2_1322_ESMFold_hypothetical_protein	3f5x-assembly1.cif.gz_A-3 CDK-2-Cyclin complex with indazole inhibitor 9 bound at its active site	0.182	291	226	176	466	4	280	1.005E-09	291
LOKIASV2_1322_ESMFold_hypothetical_protein	4eop-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4eop-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with the inhibitor RO3306	0.176	294	231	176	469	7	287	4.391E-10	291
LOKIASV2_1322_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_A GSK-3 Beta complexed with Indirubin-3'-monoxime	0.180	296	226	174	469	20	296	4.870E-10	291
LOKIASV2_1322_ESMFold_hypothetical_protein	2jd5-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2jd5-assembly1.cif.gz_A Sky1p bound to Npl3p-derived substrate peptide	0.153	321	260	160	467	2	322	9.545E-10	291
LOKIASV2_1322_ESMFold_hypothetical_protein	4uzh-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4uzh-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.165	306	204	163	468	1	245	3.139E-09	290
LOKIASV2_1322_ESMFold_hypothetical_protein	6s75-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6s75-assembly2.cif.gz_B Crystal structure of Nek7 bound to compound 51	0.167	295	207	176	470	15	263	4.067E-09	290
LOKIASV2_1322_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.161	288	221	176	463	2	266	1.174E-09	290
LOKIASV2_1322_ESMFold_hypothetical_protein	2x7f-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2x7f-assembly1.cif.gz_A Crystal structure of the kinase domain of human Traf2- and Nck- interacting Kinase with Wee1Chk1 inhibitor	0.160	301	219	176	476	11	272	9.063E-10	290
LOKIASV2_1322_ESMFold_hypothetical_protein	5dh3-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5dh3-assembly1.cif.gz_B Crystal structure of MST2 in complex with XMU-MP-1	0.176	303	227	176	478	10	285	1.559E-10	290
LOKIASV2_1322_ESMFold_hypothetical_protein	7jxy-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7jxy-assembly2.cif.gz_B Structure of TTBK1 kinase domain in complex with Compound 18	0.151	315	232	163	477	5	278	2.075E-09	290
LOKIASV2_1322_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	0.154	330	244	151	480	3	292	7.760E-10	290
LOKIASV2_1322_ESMFold_hypothetical_protein	4eon-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4eon-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with the inhibitor RO3306	0.175	291	229	176	466	6	283	6.643E-10	290
LOKIASV2_1322_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A Crystal structure of CX-4945 bound CK2 alpha from C. neoformans	0.169	327	264	150	476	3	321	2.020E-10	290
LOKIASV2_1322_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with compound 2 (AA-CS-9-003)	0.154	325	268	152	476	9	326	8.606E-10	290
LOKIASV2_1322_ESMFold_hypothetical_protein	1q97-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1q97-assembly1.cif.gz_A The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	0.151	318	258	163	467	4	321	4.624E-10	290
LOKIASV2_1322_ESMFold_hypothetical_protein	3i4b-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3i4b-assembly1.cif.gz_A Crystal structure of GSK3b in complex with a pyrimidylpyrrole inhibitor	0.187	296	235	174	469	28	317	3.056E-10	290
LOKIASV2_1322_ESMFold_hypothetical_protein	2c6e-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2c6e-assembly2.cif.gz_B Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	0.150	302	202	169	470	2	240	2.831E-09	289
LOKIASV2_1322_ESMFold_hypothetical_protein	6gra-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6gra-assembly1.cif.gz_A Human AURKA bound to BRD-7880	0.160	302	202	169	470	3	243	1.776E-09	289
LOKIASV2_1322_ESMFold_hypothetical_protein	2bmc-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	2bmc-assembly4.cif.gz_D Aurora-2 T287D T288D complexed with PHA-680632	0.165	300	205	169	468	2	247	8.172E-10	289
LOKIASV2_1322_ESMFold_hypothetical_protein	4x7h-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4x7h-assembly1.cif.gz_A Co-crystal Structure of PERK bound to N-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxamide inhibitor	0.186	297	196	167	463	1	242	1.236E-09	289
LOKIASV2_1322_ESMFold_hypothetical_protein	4x7j-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4x7j-assembly1.cif.gz_A Co-crystal Structure of PERK with 2-amino-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6-yl]benzamide inhibitor	0.184	301	202	167	467	1	249	2.301E-09	289
LOKIASV2_1322_ESMFold_hypothetical_protein	2cgu-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2cgu-assembly1.cif.gz_A Identification of chemically diverse Chk1 inhibitors by receptor- based virtual screening	0.189	292	203	171	462	1	251	5.268E-09	289
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly8.cif.gz_H	LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly8.cif.gz_H Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	0.179	323	217	162	484	6	270	1.174E-09	289
LOKIASV2_1322_ESMFold_hypothetical_protein	3mdy-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3mdy-assembly1.cif.gz_A Crystal structure of the cytoplasmic domain of the bone morphogenetic protein receptor type-1B (BMPR1B) in complex with FKBP12 and LDN-193189	0.186	302	233	176	477	31	317	4.391E-10	289
LOKIASV2_1322_ESMFold_hypothetical_protein	5zn1-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5zn1-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit in D2O	0.169	295	236	176	470	37	321	1.302E-09	289
LOKIASV2_1322_ESMFold_hypothetical_protein	6uip-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6uip-assembly1.cif.gz_A DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.	0.163	323	254	163	467	19	341	3.959E-10	289
LOKIASV2_1322_ESMFold_hypothetical_protein	4afj-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4afj-assembly2.cif.gz_B 5-aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors	0.168	290	230	174	463	21	298	1.005E-09	289
LOKIASV2_1322_ESMFold_hypothetical_protein	3beg-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3beg-assembly1.cif.gz_A Crystal structure of SR protein kinase 1 complexed to its substrate ASF/SF2	0.145	344	262	163	470	2	345	1.559E-10	289
LOKIASV2_1322_ESMFold_hypothetical_protein	7dd1-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7dd1-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with a peptide inhibitor	0.146	345	262	163	470	4	348	6.996E-10	289
LOKIASV2_1322_ESMFold_hypothetical_protein	5oy4-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5oy4-assembly2.cif.gz_B GSK3beta complex with N-(6-(3,4-dihydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)acetamide	0.189	290	227	174	463	25	305	3.759E-10	289
LOKIASV2_1322_ESMFold_hypothetical_protein	7ncf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7ncf-assembly1.cif.gz_A Crystal structure of HIPK2 in complex with MU135 (compound 21e)	0.167	350	266	163	482	6	355	1.143E-10	289
LOKIASV2_1322_ESMFold_hypothetical_protein	6fad-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6fad-assembly4.cif.gz_D SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.143	338	263	163	470	16	353	2.902E-10	289
LOKIASV2_1322_ESMFold_hypothetical_protein	5air-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5air-assembly1.cif.gz_B Structural analysis of mouse GSK3beta fused with LRP6 peptide.	0.175	290	230	174	463	33	312	4.169E-10	289
LOKIASV2_1322_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B CDPK1 from Eimeria tenella in complex with inhibitor UW1521	0.192	301	208	167	467	13	271	4.391E-10	289
LOKIASV2_1322_ESMFold_hypothetical_protein	4ztr-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4ztr-assembly1.cif.gz_A Human Aurora A catalytic domain bound to FK1141	0.170	302	200	169	470	2	243	4.510E-09	288
LOKIASV2_1322_ESMFold_hypothetical_protein	7bjr-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7bjr-assembly1.cif.gz_A Crystal structure of CHK1-10pt-mutant complex with compound 18	0.172	296	205	176	471	5	253	2.185E-09	288
LOKIASV2_1322_ESMFold_hypothetical_protein	6brc-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6brc-assembly2.cif.gz_B Crystal Structure of the Human CAMKK2B in complex with AP26113-analog (ALK-IN-1)	0.157	291	213	176	466	5	258	4.067E-09	288
LOKIASV2_1322_ESMFold_hypothetical_protein	2x8i-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2x8i-assembly1.cif.gz_A Discovery of a Novel Class of triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration	0.185	296	204	176	471	8	258	2.688E-09	288
LOKIASV2_1322_ESMFold_hypothetical_protein	4ks8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4ks8-assembly1.cif.gz_A PAK6 kinase domain in complex with sunitinib	0.151	292	214	176	467	23	275	1.206E-08	288
LOKIASV2_1322_ESMFold_hypothetical_protein	7aj5-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7aj5-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 10	0.159	327	258	163	470	1	327	4.391E-10	288
LOKIASV2_1322_ESMFold_hypothetical_protein	5kpl-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5kpl-assembly2.cif.gz_B Glycogen Synthase Kinase 3 beta Complexed with BRD0705	0.188	290	222	174	463	19	292	1.174E-09	288
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_F	LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_F CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.157	325	244	151	475	49	338	1.174E-09	288
LOKIASV2_1322_ESMFold_hypothetical_protein	2clq-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	2clq-assembly1.cif.gz_A-2 Structure of mitogen-activated protein kinase kinase kinase 5	0.188	304	207	163	466	1	256	2.552E-09	287
LOKIASV2_1322_ESMFold_hypothetical_protein	3ma6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3ma6-assembly1.cif.gz_A Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	0.183	301	216	170	470	1	265	3.667E-09	287
LOKIASV2_1322_ESMFold_hypothetical_protein	2duv-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2duv-assembly1.cif.gz_A Structure of CDK2 with a 3-hydroxychromones	0.156	298	218	176	473	4	262	2.831E-09	287
LOKIASV2_1322_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.177	288	218	176	463	3	268	1.371E-09	287
LOKIASV2_1322_ESMFold_hypothetical_protein	3gok-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3gok-assembly1.cif.gz_A Binding site mapping of protein ligands	0.168	323	230	162	484	6	282	7.368E-10	287
LOKIASV2_1322_ESMFold_hypothetical_protein	3gok-assembly1.cif.gz_G	LOKIASV2_1322_ESMFold_hypothetical_protein	3gok-assembly1.cif.gz_G Binding site mapping of protein ligands	0.174	323	229	162	484	6	283	7.760E-10	287
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly3.cif.gz_L	LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly3.cif.gz_L MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	0.190	327	221	159	485	4	277	3.056E-10	287
LOKIASV2_1322_ESMFold_hypothetical_protein	4twc-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4twc-assembly2.cif.gz_B 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of CK1d/e	0.150	308	235	167	474	1	278	5.268E-09	287
LOKIASV2_1322_ESMFold_hypothetical_protein	8c12-assembly1.cif.gz_AAA	LOKIASV2_1322_ESMFold_hypothetical_protein	8c12-assembly1.cif.gz_AAA Identification of an intermediate activation state of PAK5 reveals a novel mechanism of kinase inhibition.	0.148	319	227	152	470	8	275	3.139E-09	287
LOKIASV2_1322_ESMFold_hypothetical_protein	2xmy-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2xmy-assembly1.cif.gz_A Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents	0.170	294	232	176	469	4	283	1.302E-09	287
LOKIASV2_1322_ESMFold_hypothetical_protein	2qlu-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2qlu-assembly1.cif.gz_A Crystal structure of Activin receptor type II kinase domain from human	0.158	294	245	176	469	3	294	1.602E-09	287
LOKIASV2_1322_ESMFold_hypothetical_protein	6qy8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6qy8-assembly1.cif.gz_A Human CSNK2A2 bound to ERB-041	0.159	295	237	176	470	33	315	4.391E-10	287
LOKIASV2_1322_ESMFold_hypothetical_protein	6s1i-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6s1i-assembly2.cif.gz_B Crystal Structure of DYRK1A with small molecule inhibitor	0.172	326	252	163	467	15	340	6.643E-10	287
LOKIASV2_1322_ESMFold_hypothetical_protein	4jrn-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4jrn-assembly1.cif.gz_A ROP18 kinase domain in complex with AMP-PNP and sucrose	0.151	331	267	154	484	35	349	9.291E-11	287
LOKIASV2_1322_ESMFold_hypothetical_protein	6sgd-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6sgd-assembly1.cif.gz_A Nek2 kinase covalently bound to 2-arylamino-6-ethynylpurine inhibitor 24	0.157	286	194	176	461	6	236	1.776E-09	286
LOKIASV2_1322_ESMFold_hypothetical_protein	6bwk-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6bwk-assembly1.cif.gz_A Crystal structure of the human MLKL pseudokinase domain T357E/S358E mutant	0.158	290	207	180	469	16	262	1.236E-09	286
LOKIASV2_1322_ESMFold_hypothetical_protein	3d5x-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3d5x-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with wortmannin.	0.159	324	229	163	486	1	273	3.482E-09	286
LOKIASV2_1322_ESMFold_hypothetical_protein	2x7f-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2x7f-assembly2.cif.gz_B Crystal structure of the kinase domain of human Traf2- and Nck- interacting Kinase with Wee1Chk1 inhibitor	0.152	308	240	169	476	1	284	4.391E-10	286
LOKIASV2_1322_ESMFold_hypothetical_protein	6s1f-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6s1f-assembly1.cif.gz_A Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	0.192	309	210	173	481	16	276	8.172E-10	286
LOKIASV2_1322_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A Crystal Structure of maize CK2 in complex with the inhibitor apigenin	0.160	327	270	150	476	3	324	3.218E-10	286
LOKIASV2_1322_ESMFold_hypothetical_protein	3anr-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	3anr-assembly3.cif.gz_C human DYRK1A/harmine complex	0.169	317	253	163	467	16	332	3.389E-10	286
LOKIASV2_1322_ESMFold_hypothetical_protein	2wei-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2wei-assembly1.cif.gz_A Crystal structure of the kinase domain of Cryptosporidium parvum calcium dependent protein kinase in complex with 3-MB-PP1	0.183	295	208	176	470	16	271	2.831E-09	285
LOKIASV2_1322_ESMFold_hypothetical_protein	7nry-assembly1.cif.gz_X	LOKIASV2_1322_ESMFold_hypothetical_protein	7nry-assembly1.cif.gz_X Re-refinement of MAPKAP kinase-2/inhibitor complex 3fyj	0.171	302	189	176	477	19	247	1.776E-09	285
LOKIASV2_1322_ESMFold_hypothetical_protein	6unq-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6unq-assembly1.cif.gz_A Kinase domain of ALK2-K493A with AMPPNP	0.181	291	233	176	466	3	288	5.990E-10	285
LOKIASV2_1322_ESMFold_hypothetical_protein	8buq-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8buq-assembly1.cif.gz_B Structure of DDB1 bound to DS43-engaged CDK12-cyclin K	0.158	292	240	176	467	13	298	5.128E-10	285
LOKIASV2_1322_ESMFold_hypothetical_protein	3l1s-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3l1s-assembly1.cif.gz_A 3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3	0.195	296	216	174	469	27	295	5.401E-10	285
LOKIASV2_1322_ESMFold_hypothetical_protein	1wbp-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1wbp-assembly1.cif.gz_A SRPK1 bound to 9mer docking motif peptide	0.140	347	267	160	470	1	347	3.056E-10	285
LOKIASV2_1322_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.166	302	205	169	470	2	248	2.423E-09	284
LOKIASV2_1322_ESMFold_hypothetical_protein	4fkj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4fkj-assembly1.cif.gz_A Crystal structure of the cdk2 in complex with aminopyrazole inhibitor	0.172	292	214	176	467	4	262	2.301E-09	284
LOKIASV2_1322_ESMFold_hypothetical_protein	5k3y-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5k3y-assembly2.cif.gz_B Crystal structure of AuroraB/INCENP in complex with BI 811283	0.160	310	220	161	470	2	264	9.545E-10	284
LOKIASV2_1322_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP	0.179	316	235	169	484	1	287	1.302E-09	284
LOKIASV2_1322_ESMFold_hypothetical_protein	6gu2-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6gu2-assembly1.cif.gz_A CDK1/CyclinB/Cks2 in complex with Flavopiridol	0.177	309	236	176	484	7	294	1.236E-09	284
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbo-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2jbo-assembly1.cif.gz_A Protein kinase MK2 in complex with an inhibitor (crystal form-1, soaking)	0.183	323	225	162	484	8	283	5.401E-10	284
LOKIASV2_1322_ESMFold_hypothetical_protein	7a4s-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7a4s-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 2	0.172	325	252	163	467	1	325	4.870E-10	284
LOKIASV2_1322_ESMFold_hypothetical_protein	6l24-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6l24-assembly1.cif.gz_A Crystal structure of CK2a1 H115Y/V116I with hematein	0.152	317	257	163	479	30	333	8.606E-10	284
LOKIASV2_1322_ESMFold_hypothetical_protein	6eir-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6eir-assembly2.cif.gz_B DYRK1A in complex with XMD15-27-2	0.173	314	251	163	467	17	330	4.870E-10	284
LOKIASV2_1322_ESMFold_hypothetical_protein	6y9s-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6y9s-assembly2.cif.gz_B Crystal structure of GSK-3b in complex with the imidazo[1,5-a]pyridine-3-carboxamide inhibitor 16	0.186	295	233	167	461	4	290	7.368E-10	284
LOKIASV2_1322_ESMFold_hypothetical_protein	5a3x-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5a3x-assembly1.cif.gz_A DYRK1A in complex with hydroxy benzothiazole fragment	0.172	325	254	163	470	16	340	6.643E-10	284
LOKIASV2_1322_ESMFold_hypothetical_protein	5mxx-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5mxx-assembly1.cif.gz_A Crystal structure of human SR protein kinase 1 (SRPK1) in complex with compound 1	0.142	344	263	163	470	15	358	7.368E-10	284
LOKIASV2_1322_ESMFold_hypothetical_protein	5odt-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5odt-assembly1.cif.gz_A Aurora-A in complex with TACC3	0.152	304	209	167	470	1	248	3.862E-09	283
LOKIASV2_1322_ESMFold_hypothetical_protein	8bzi-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8bzi-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with inhibitor MR39	0.198	303	204	176	478	11	265	8.606E-10	283
LOKIASV2_1322_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A Crystal structure of CDK2 liganded with compound WN316	0.176	294	220	176	469	2	269	2.981E-09	283
LOKIASV2_1322_ESMFold_hypothetical_protein	3a7f-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3a7f-assembly1.cif.gz_A Human MST3 kinase	0.188	308	218	176	483	16	284	2.688E-09	283
LOKIASV2_1322_ESMFold_hypothetical_protein	6fd3-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6fd3-assembly1.cif.gz_A Thiophosphorylated PAK3 kinase domain	0.163	331	242	152	482	7	296	6.643E-10	283
LOKIASV2_1322_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_B-2	LOKIASV2_1322_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_B-2 Crystal structure of Cka1p, a casein kinase 2 alpha ortholog from Candida albicans	0.160	330	265	150	479	9	324	5.401E-10	283
LOKIASV2_1322_ESMFold_hypothetical_protein	4afj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4afj-assembly1.cif.gz_A 5-aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors	0.177	297	230	174	470	19	299	2.755E-10	283
LOKIASV2_1322_ESMFold_hypothetical_protein	6v6l-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6v6l-assembly1.cif.gz_A Co-structure of human glycogen synthase kinase beta with 1-(6-((2-((6-amino-5-nitropyridin-2-yl)amino)ethyl)amino)-2-(2,4-dichlorophenyl)pyridin-3-yl)-4-methylpiperazin-2-one	0.185	297	238	167	463	3	295	3.056E-10	283
LOKIASV2_1322_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A Crystal structure of P8C9 bound to CK2alpha	0.165	306	247	170	475	47	343	1.236E-09	283
LOKIASV2_1322_ESMFold_hypothetical_protein	6cd6-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6cd6-assembly4.cif.gz_D Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.163	299	222	169	467	1	266	1.033E-08	282
LOKIASV2_1322_ESMFold_hypothetical_protein	2fvd-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2fvd-assembly1.cif.gz_A Cyclin Dependent Kinase 2 (CDK2) with diaminopyrimidine inhibitor	0.164	294	224	176	469	4	272	2.075E-09	282
LOKIASV2_1322_ESMFold_hypothetical_protein	7psu-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7psu-assembly2.cif.gz_B Structure of protein kinase CK2alpha mutant K198R associated with the Okur-Chung Neurodevelopmental Syndrome	0.162	319	255	158	476	26	330	2.301E-09	282
LOKIASV2_1322_ESMFold_hypothetical_protein	3anq-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3anq-assembly1.cif.gz_A human DYRK1A/inhibitor complex	0.157	325	259	163	470	16	340	2.359E-10	282
LOKIASV2_1322_ESMFold_hypothetical_protein	7s6v-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7s6v-assembly1.cif.gz_A Leishmania infantum Glycogen Synthase Kinase 3 beta bound to CGP60474	0.201	295	227	176	470	20	304	5.990E-10	282
LOKIASV2_1322_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	0.156	360	266	163	478	2	361	5.128E-10	282
LOKIASV2_1322_ESMFold_hypothetical_protein	2wqn-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2wqn-assembly1.cif.gz_A Structure of ADP-bound human Nek7	0.163	295	202	176	470	14	255	1.033E-08	281
LOKIASV2_1322_ESMFold_hypothetical_protein	4f0g-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4f0g-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain from D. discoideum	0.162	294	211	176	469	11	263	7.187E-09	281
LOKIASV2_1322_ESMFold_hypothetical_protein	5h8g-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5h8g-assembly1.cif.gz_A Crystal structure of CK2 with compound 7b	0.157	323	265	152	474	9	323	7.368E-10	281
LOKIASV2_1322_ESMFold_hypothetical_protein	1q4l-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1q4l-assembly1.cif.gz_B GSK-3 Beta complexed with Inhibitor I-5	0.183	306	230	174	479	20	302	8.172E-10	281
LOKIASV2_1322_ESMFold_hypothetical_protein	6uip-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6uip-assembly2.cif.gz_B DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.	0.160	322	255	163	467	14	335	4.870E-10	281
LOKIASV2_1322_ESMFold_hypothetical_protein	5aik-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	5aik-assembly4.cif.gz_D Human DYRK1A in complex with LDN-211898	0.159	323	256	163	467	16	338	3.056E-10	281
LOKIASV2_1322_ESMFold_hypothetical_protein	7o7k-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7o7k-assembly1.cif.gz_A Crystal structure of the human DYRK1A kinase domain bound to abemaciclib	0.173	325	251	163	467	16	340	6.308E-10	281
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_D MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	0.182	324	211	162	485	6	264	2.831E-09	280
LOKIASV2_1322_ESMFold_hypothetical_protein	3sw7-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3sw7-assembly1.cif.gz_A Crystal Structure of the CDK2 in complex with thiazolylpyrimidine inhibitor	0.166	292	215	176	467	4	262	3.306E-09	280
LOKIASV2_1322_ESMFold_hypothetical_protein	6hmr-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6hmr-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with a photoswitchable 2-Azothiazole-based inhibitor (compound 2)	0.158	306	222	169	474	4	268	5.268E-09	280
LOKIASV2_1322_ESMFold_hypothetical_protein	4fkq-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4fkq-assembly1.cif.gz_A Crystal structure of the cdk2 in complex with oxindole inhibitor	0.179	294	219	176	469	4	271	1.687E-09	280
LOKIASV2_1322_ESMFold_hypothetical_protein	5zn2-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5zn2-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit H148A mutant	0.154	295	238	176	470	37	318	2.423E-09	280
LOKIASV2_1322_ESMFold_hypothetical_protein	5kpl-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5kpl-assembly1.cif.gz_A Glycogen Synthase Kinase 3 beta Complexed with BRD0705	0.172	290	225	174	463	19	291	1.236E-09	280
LOKIASV2_1322_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_B GSK-3 Beta complexed with Indirubin-3'-monoxime	0.182	296	231	174	469	20	303	9.063E-10	280
LOKIASV2_1322_ESMFold_hypothetical_protein	7zks-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7zks-assembly1.cif.gz_A SRPK1 IN COMPLEX WITH INHIBITOR	0.145	342	262	163	470	4	345	1.005E-09	280
LOKIASV2_1322_ESMFold_hypothetical_protein	8ahp-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8ahp-assembly1.cif.gz_A The crystal structure of the truncated form of Lotus japonicus kinase 1	0.191	310	244	161	463	2	311	2.359E-10	280
LOKIASV2_1322_ESMFold_hypothetical_protein	6ccf-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6ccf-assembly2.cif.gz_B Crystal Structure of the Human CAMKK1A in complex with Hesperadin	0.153	299	220	169	467	1	261	1.033E-08	279
LOKIASV2_1322_ESMFold_hypothetical_protein	2w5h-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2w5h-assembly1.cif.gz_A Human Nek2 kinase Apo	0.173	286	204	176	461	6	253	1.871E-09	279
LOKIASV2_1322_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-3	0.187	322	222	164	485	1	274	4.750E-09	279
LOKIASV2_1322_ESMFold_hypothetical_protein	2f2c-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2f2c-assembly1.cif.gz_B X-ray structure of human CDK6-Vcyclinwith the inhibitor aminopurvalanol	0.184	282	213	189	470	13	274	6.643E-10	279
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_J	LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_J MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	0.178	326	223	159	484	3	274	1.335E-10	279
LOKIASV2_1322_ESMFold_hypothetical_protein	5xv7-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5xv7-assembly1.cif.gz_A SRPK1 in complex with Alectinib	0.154	344	260	163	470	4	347	4.391E-10	279
LOKIASV2_1322_ESMFold_hypothetical_protein	3daj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3daj-assembly1.cif.gz_A Crystal structure of Aurora A complexed with an inhibitor discovered through site-directed dynamic tethering	0.153	302	201	169	470	2	239	5.843E-09	278
LOKIASV2_1322_ESMFold_hypothetical_protein	6ccf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6ccf-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with Hesperadin	0.153	299	219	169	467	1	259	3.306E-09	278
LOKIASV2_1322_ESMFold_hypothetical_protein	1ke8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1ke8-assembly1.cif.gz_A CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE	0.173	294	220	176	469	4	270	2.831E-09	278
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly4.cif.gz_D Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	0.186	323	216	162	484	5	270	7.760E-10	278
LOKIASV2_1322_ESMFold_hypothetical_protein	6yat-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6yat-assembly1.cif.gz_A Crystal structure of STK4 (MST1) in complex with compound 6	0.185	303	227	176	478	13	291	3.056E-10	278
LOKIASV2_1322_ESMFold_hypothetical_protein	5osm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5osm-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent adduct at C80	0.176	306	227	162	467	3	278	8.606E-10	278
LOKIASV2_1322_ESMFold_hypothetical_protein	8edh-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8edh-assembly1.cif.gz_A Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	0.164	295	199	168	462	10	248	6.480E-09	277
LOKIASV2_1322_ESMFold_hypothetical_protein	2w5b-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2w5b-assembly1.cif.gz_A Human Nek2 kinase ATPgammaS-bound	0.181	286	207	176	461	6	259	3.667E-09	277
LOKIASV2_1322_ESMFold_hypothetical_protein	8qlq-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8qlq-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with macrocyclic inhibitor JA310	0.193	303	215	176	478	10	277	1.371E-09	277
LOKIASV2_1322_ESMFold_hypothetical_protein	2rgp-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2rgp-assembly1.cif.gz_A Structure of EGFR in complex with hydrazone, a potent dual inhibitor	0.154	317	222	168	484	5	268	5.002E-09	277
LOKIASV2_1322_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_D Structure of the OSR1 kinase, a hypertension drug target	0.159	292	224	176	467	12	278	1.174E-09	277
LOKIASV2_1322_ESMFold_hypothetical_protein	5d7a-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5d7a-assembly2.cif.gz_B Crystal structure of the kinase domain of TRAF2 and NCK-interacting protein kinase with NCB-0846	0.154	298	228	176	473	15	285	1.059E-09	277
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_E MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	0.180	330	225	156	485	2	276	1.174E-09	277
LOKIASV2_1322_ESMFold_hypothetical_protein	5zn3-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5zn3-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit H148S mutant	0.156	308	244	163	470	29	318	3.482E-09	277
LOKIASV2_1322_ESMFold_hypothetical_protein	3w8l-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3w8l-assembly2.cif.gz_B Crystal structure of human CK2 in complex with inositol hexakisphosphate	0.163	300	242	176	475	36	325	3.482E-09	277
LOKIASV2_1322_ESMFold_hypothetical_protein	4md9-assembly1.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	4md9-assembly1.cif.gz_E Crystal Structure of symmetric CK2 holoenzyme with mutated alpha subunit (F121E truncated at aa 336)	0.152	324	259	159	482	24	329	3.667E-09	277
LOKIASV2_1322_ESMFold_hypothetical_protein	1ias-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1ias-assembly1.cif.gz_A CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12	0.188	295	236	176	470	35	326	2.902E-10	277
LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly4.cif.gz_D Crystal structure of SRPK2 in complex with compound 1	0.152	345	260	163	470	4	348	6.643E-10	277
LOKIASV2_1322_ESMFold_hypothetical_protein	3h10-assembly3.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	3h10-assembly3.cif.gz_D Aurora A inhibitor complex	0.166	302	205	169	470	3	249	1.871E-09	276
LOKIASV2_1322_ESMFold_hypothetical_protein	2phk-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	2phk-assembly1.cif.gz_A-2 THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION	0.159	291	225	170	460	1	269	3.306E-09	276
LOKIASV2_1322_ESMFold_hypothetical_protein	3lfn-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3lfn-assembly1.cif.gz_A Crystal structure of CDK2 with SAR57, an aminoindazole type inhibitor	0.175	292	219	176	467	4	269	1.059E-09	276
LOKIASV2_1322_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactive state.	0.175	292	213	176	467	10	268	4.067E-09	276
LOKIASV2_1322_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B Crystal structure of Casein kinase I homolog 1	0.166	306	234	169	474	2	282	1.521E-09	276
LOKIASV2_1322_ESMFold_hypothetical_protein	7akb-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7akb-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 56	0.167	322	253	163	467	8	329	2.981E-09	276
LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_B Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.158	299	213	169	467	5	258	1.562E-08	275
LOKIASV2_1322_ESMFold_hypothetical_protein	6vre-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6vre-assembly2.cif.gz_B Structure of ASK1 bound to BIO-1772961	0.191	301	203	163	463	2	253	1.059E-09	275
LOKIASV2_1322_ESMFold_hypothetical_protein	2bts-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2bts-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032	0.164	295	215	176	470	4	261	3.667E-09	275
LOKIASV2_1322_ESMFold_hypothetical_protein	7nzy-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7nzy-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with CGS-15943	0.168	306	225	169	474	2	273	2.831E-09	275
LOKIASV2_1322_ESMFold_hypothetical_protein	3pj8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3pj8-assembly1.cif.gz_A Structure of CDK2 in complex with a Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine.	0.177	294	223	176	469	5	276	2.552E-09	275
LOKIASV2_1322_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A Structure of Human YSK1 (Yeast Sps1-Ste20-related Kinase 1)	0.196	299	217	176	474	18	288	2.359E-10	275
LOKIASV2_1322_ESMFold_hypothetical_protein	6eiv-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6eiv-assembly2.cif.gz_B DYRK1A in complex with JWD-065	0.163	319	254	163	467	17	335	5.401E-10	275
LOKIASV2_1322_ESMFold_hypothetical_protein	6fad-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6fad-assembly3.cif.gz_C SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.140	341	264	163	470	16	356	4.624E-10	275
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_G	LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_G CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.158	325	244	151	475	51	341	1.871E-09	275
LOKIASV2_1322_ESMFold_hypothetical_protein	4wot-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4wot-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH 1426382-07-1	0.156	335	256	151	485	52	355	1.302E-09	275
LOKIASV2_1322_ESMFold_hypothetical_protein	3igo-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3igo-assembly1.cif.gz_A Crystal structure of Cryptosporidium parvum CDPK1, cgd3_920	0.176	303	213	169	471	2	260	3.482E-09	275
LOKIASV2_1322_ESMFold_hypothetical_protein	2w5a-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2w5a-assembly1.cif.gz_A Human Nek2 kinase ADP-bound	0.165	286	208	176	461	6	255	1.236E-09	274
LOKIASV2_1322_ESMFold_hypothetical_protein	4fki-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4fki-assembly1.cif.gz_A Crystal Structure of the Cdk2 in Complex with Aminopyrazole Inhibitor	0.173	292	221	176	467	4	271	1.602E-09	274
LOKIASV2_1322_ESMFold_hypothetical_protein	3ocb-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3ocb-assembly1.cif.gz_A Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.158	317	238	169	485	2	285	2.688E-09	274
LOKIASV2_1322_ESMFold_hypothetical_protein	1tki-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1tki-assembly1.cif.gz_A AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN	0.180	295	207	176	470	7	260	6.825E-09	274
LOKIASV2_1322_ESMFold_hypothetical_protein	3qkk-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3qkk-assembly1.cif.gz_A Spirochromane Akt Inhibitors	0.147	310	237	176	485	7	285	2.301E-09	274
LOKIASV2_1322_ESMFold_hypothetical_protein	4cxa-assembly2.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4cxa-assembly2.cif.gz_A Crystal structure of the human CDK12-cyclin K complex bound to AMPPNP	0.150	307	253	176	482	10	308	5.401E-10	274
LOKIASV2_1322_ESMFold_hypothetical_protein	1q4l-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1q4l-assembly1.cif.gz_A GSK-3 Beta complexed with Inhibitor I-5	0.188	306	231	174	479	20	304	1.302E-09	274
LOKIASV2_1322_ESMFold_hypothetical_protein	7cga-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	7cga-assembly3.cif.gz_C Crystal structure of human unphosphorylated p38gamma	0.167	318	258	167	484	6	316	1.559E-10	274
LOKIASV2_1322_ESMFold_hypothetical_protein	5uvc-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5uvc-assembly1.cif.gz_A Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.174	330	242	153	482	121	414	8.172E-10	274
LOKIASV2_1322_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_A Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	0.167	273	195	176	448	3	237	1.562E-08	273
LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.184	287	191	176	462	8	242	2.981E-09	273
LOKIASV2_1322_ESMFold_hypothetical_protein	4bie-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4bie-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.183	304	203	163	466	1	249	1.871E-09	273
LOKIASV2_1322_ESMFold_hypothetical_protein	5jq5-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5jq5-assembly1.cif.gz_A Crystal structure of CDK2 in complex with inhibitor ICEC0942	0.173	294	226	176	469	2	275	2.981E-09	273
LOKIASV2_1322_ESMFold_hypothetical_protein	4ekk-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4ekk-assembly1.cif.gz_A Akt1 with AMP-PNP	0.165	317	242	169	485	2	292	2.075E-09	273
LOKIASV2_1322_ESMFold_hypothetical_protein	3mdy-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	3mdy-assembly2.cif.gz_C Crystal structure of the cytoplasmic domain of the bone morphogenetic protein receptor type-1B (BMPR1B) in complex with FKBP12 and LDN-193189	0.192	302	233	176	477	31	319	1.059E-09	273
LOKIASV2_1322_ESMFold_hypothetical_protein	5zn4-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5zn4-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit H148N mutant	0.164	308	244	163	470	29	321	3.139E-09	273
LOKIASV2_1322_ESMFold_hypothetical_protein	7a53-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7a53-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 7	0.162	322	255	163	467	7	328	4.391E-10	273
LOKIASV2_1322_ESMFold_hypothetical_protein	5t31-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5t31-assembly1.cif.gz_A Exploiting an Asp-Glu switch in Glycogen Synthase Kinase 3 to design paralog selective inhibitors for use in acute myeloid leukemia	0.177	312	239	174	485	20	310	2.552E-09	273
LOKIASV2_1322_ESMFold_hypothetical_protein	5z33-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5z33-assembly1.cif.gz_A Crystal structure of Mitogen-activated Protein Kinase Mps1 in Magnaporthe oryzae	0.191	312	250	164	473	1	312	7.955E-11	273
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.159	335	253	151	485	51	352	1.871E-09	273
LOKIASV2_1322_ESMFold_hypothetical_protein	5u7q-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	5u7q-assembly3.cif.gz_C Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	0.156	335	257	151	485	51	355	1.302E-09	273
LOKIASV2_1322_ESMFold_hypothetical_protein	5ezr-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5ezr-assembly1.cif.gz_A Crystal Structure of PVX_084705 bound to compound	0.163	313	233	165	477	513	791	1.970E-09	273
LOKIASV2_1322_ESMFold_hypothetical_protein	5knj-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5knj-assembly2.cif.gz_B Pseudokinase Domain of MLKL bound to Compound 1.	0.153	289	205	180	468	16	258	7.971E-09	272
LOKIASV2_1322_ESMFold_hypothetical_protein	5oop-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5oop-assembly1.cif.gz_A Structure of CHK1 10-pt. mutant complex with AMP-PNP	0.174	287	202	176	462	5	249	9.310E-09	272
LOKIASV2_1322_ESMFold_hypothetical_protein	7b31-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7b31-assembly1.cif.gz_A MST3 in complex with compound MRIA9	0.192	303	204	176	478	11	264	2.423E-09	272
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_G	LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_G MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	0.175	322	215	156	477	3	264	6.153E-09	272
LOKIASV2_1322_ESMFold_hypothetical_protein	1ke9-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1ke9-assembly1.cif.gz_A CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE	0.174	292	216	176	467	4	265	4.067E-09	272
LOKIASV2_1322_ESMFold_hypothetical_protein	3r9o-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3r9o-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-143	0.176	292	216	176	467	4	266	3.667E-09	272
LOKIASV2_1322_ESMFold_hypothetical_protein	7sxj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7sxj-assembly1.cif.gz_A BIO-2895 (BRD0705) bound GSK3beta-axin complex	0.171	290	230	174	463	22	299	3.862E-09	272
LOKIASV2_1322_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_A Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	0.172	273	196	176	448	3	240	2.908E-08	271
LOKIASV2_1322_ESMFold_hypothetical_protein	4c3p-assembly1.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4c3p-assembly1.cif.gz_D Structure of dephosphorylated Aurora A (122-403) bound to TPX2 and AMPPCP	0.149	300	214	169	468	4	255	1.409E-08	271
LOKIASV2_1322_ESMFold_hypothetical_protein	7b32-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7b32-assembly1.cif.gz_A MST3 in complex with MRIA7	0.198	303	202	176	478	11	263	2.981E-09	271
LOKIASV2_1322_ESMFold_hypothetical_protein	2wma-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	2wma-assembly2.cif.gz_C Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin A	0.197	291	198	176	466	5	251	8.841E-09	271
LOKIASV2_1322_ESMFold_hypothetical_protein	1v1k-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1v1k-assembly1.cif.gz_A CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR	0.165	294	218	176	469	4	265	8.841E-09	271
LOKIASV2_1322_ESMFold_hypothetical_protein	6q3b-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6q3b-assembly1.cif.gz_A CDK2 in complex with FragLite2	0.179	294	219	176	469	4	271	2.981E-09	271
LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_D Crystal Structure of Domain-Swapped OSR1 kinase domain	0.145	305	239	163	467	1	281	2.075E-09	271
LOKIASV2_1322_ESMFold_hypothetical_protein	4btj-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4btj-assembly2.cif.gz_B TTBK1 in complex with ATP	0.156	315	235	163	477	4	282	1.825E-08	271
LOKIASV2_1322_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A Cdk2(F80C) with Covalent Adduct TK22 at F80C	0.167	303	235	167	469	1	283	2.981E-09	271
LOKIASV2_1322_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A The crystal structure of MPK38 in complex with OTSSP167, an orally- administrative MELK selective inhibitor	0.168	299	198	176	474	10	248	4.283E-09	271
LOKIASV2_1322_ESMFold_hypothetical_protein	6fvg-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6fvg-assembly1.cif.gz_A The Structure of CK2alpha with CCh507 bound	0.150	301	246	170	470	32	321	3.139E-09	271
LOKIASV2_1322_ESMFold_hypothetical_protein	6ae3-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6ae3-assembly2.cif.gz_D Crystal structure of GSK3beta complexed with Morin	0.185	296	225	174	469	19	295	1.687E-09	271
LOKIASV2_1322_ESMFold_hypothetical_protein	4b99-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4b99-assembly1.cif.gz_A Crystal Structure of MAPK7 (ERK5) with inhibitor	0.166	309	242	176	484	9	299	3.389E-10	271
LOKIASV2_1322_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A Crystal structure of PF14_0431, kinase domain.	0.140	327	257	163	462	8	334	3.570E-10	271
LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_E Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.178	295	200	169	463	5	248	2.761E-08	270
LOKIASV2_1322_ESMFold_hypothetical_protein	5de2-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5de2-assembly2.cif.gz_B Structural mechanism of Nek7 activation by Nek9-induced dimerisation	0.156	295	205	176	470	15	258	7.569E-09	270
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_G	LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_G Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	0.167	316	217	163	478	2	262	4.283E-09	270
LOKIASV2_1322_ESMFold_hypothetical_protein	2r3m-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2r3m-assembly1.cif.gz_A Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor	0.174	292	214	176	467	4	263	5.843E-09	270
LOKIASV2_1322_ESMFold_hypothetical_protein	2wtk-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	2wtk-assembly2.cif.gz_C Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	0.167	287	209	176	462	3	254	8.395E-09	270
LOKIASV2_1322_ESMFold_hypothetical_protein	3d0e-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3d0e-assembly1.cif.gz_A Crystal structure of human Akt2 in complex with GSK690693	0.136	317	244	169	485	2	284	2.831E-09	270
LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly2.cif.gz_C Phosphorylated p38 and MAPKAPK2 complex with inhibitor	0.177	319	231	162	480	1	282	1.059E-09	270
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_H	LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_H CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.162	324	241	151	474	49	337	2.075E-09	270
LOKIASV2_1322_ESMFold_hypothetical_protein	3h0z-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	3h0z-assembly3.cif.gz_C Aurora A in complex with a bisanilinopyrimidine	0.143	302	207	167	468	1	243	1.733E-08	269
LOKIASV2_1322_ESMFold_hypothetical_protein	4kb8-assembly5.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4kb8-assembly5.cif.gz_A CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand	0.148	306	215	169	474	1	253	2.761E-08	269
LOKIASV2_1322_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	0.176	297	206	169	465	2	252	1.270E-08	269
LOKIASV2_1322_ESMFold_hypothetical_protein	1gii-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1gii-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR	0.183	293	214	176	468	4	266	9.805E-09	269
LOKIASV2_1322_ESMFold_hypothetical_protein	3sv0-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3sv0-assembly1.cif.gz_A Crystal structure of casein kinase-1 like protein in plant	0.174	310	231	169	478	2	282	1.145E-08	269
LOKIASV2_1322_ESMFold_hypothetical_protein	6bu6-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6bu6-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a bis-difluorophenol-aminopyridine inhibitor	0.147	304	255	163	466	2	301	1.115E-09	269
LOKIASV2_1322_ESMFold_hypothetical_protein	5cyz-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5cyz-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 1	0.147	312	241	168	479	3	285	8.841E-09	269
LOKIASV2_1322_ESMFold_hypothetical_protein	2j50-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2j50-assembly2.cif.gz_B Structure of Aurora-2 in complex with PHA-739358	0.159	302	204	169	470	1	243	6.153E-09	268
LOKIASV2_1322_ESMFold_hypothetical_protein	5knj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5knj-assembly1.cif.gz_A Pseudokinase Domain of MLKL bound to Compound 1.	0.151	288	200	180	467	15	251	1.733E-08	268
LOKIASV2_1322_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2)	0.155	300	210	169	468	2	251	9.310E-09	268
LOKIASV2_1322_ESMFold_hypothetical_protein	5oq5-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5oq5-assembly1.cif.gz_A Structure of CHK1 8-pt. mutant complex with aminopyrimido-benzodiazepinone LRRK2 inhibitor	0.188	287	201	176	462	7	254	1.338E-08	268
LOKIASV2_1322_ESMFold_hypothetical_protein	2w05-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2w05-assembly1.cif.gz_A Structure of CDK2 in complex with an imidazolyl pyrimidine, compound 5b	0.158	295	218	176	470	4	263	7.971E-09	268
LOKIASV2_1322_ESMFold_hypothetical_protein	5uu1-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5uu1-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to BI-D1870	0.142	304	256	164	467	3	301	9.063E-10	268
LOKIASV2_1322_ESMFold_hypothetical_protein	1j91-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1j91-assembly1.cif.gz_A Crystal structure of Z. mays CK2 kinase alpha subunit in complex with the ATP-competitive inhibitor 4,5,6,7-tetrabromobenzotriazole	0.166	327	268	152	478	5	326	5.843E-09	268
LOKIASV2_1322_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A Crystal structure of non-phosphorylated Fus3	0.171	321	250	163	483	1	302	1.918E-10	268
LOKIASV2_1322_ESMFold_hypothetical_protein	7zkx-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7zkx-assembly1.cif.gz_A SRPK2 IN COMPLEX WITH INHIBITOR	0.155	337	256	163	466	2	338	9.805E-09	268
LOKIASV2_1322_ESMFold_hypothetical_protein	2xnm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2xnm-assembly1.cif.gz_A Structure of NEK2 bound to CCT	0.165	286	200	176	461	6	246	4.067E-09	267
LOKIASV2_1322_ESMFold_hypothetical_protein	4bic-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4bic-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.184	308	207	163	470	1	255	5.843E-09	267
LOKIASV2_1322_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_C Structure of the OSR1 kinase, a hypertension drug target	0.149	288	218	176	463	9	265	3.667E-09	267
LOKIASV2_1322_ESMFold_hypothetical_protein	1h08-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1h08-assembly1.cif.gz_A CDK2 in complex with a disubstituted 2, 4-bis anilino pyrimidine CDK4 inhibitor	0.175	292	217	176	467	4	267	3.862E-09	267
LOKIASV2_1322_ESMFold_hypothetical_protein	3unk-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3unk-assembly1.cif.gz_A CDK2 in complex with inhibitor YL5-083	0.173	294	231	176	469	4	283	2.981E-09	267
LOKIASV2_1322_ESMFold_hypothetical_protein	6s1b-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6s1b-assembly1.cif.gz_A Crystal Structure of DYRK1A with small molecule inhibitor	0.160	318	255	163	467	15	332	7.760E-10	267
LOKIASV2_1322_ESMFold_hypothetical_protein	4fr4-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4fr4-assembly3.cif.gz_C Crystal structure of human serine/threonine-protein kinase 32A (YANK1)	0.160	322	242	165	486	1	289	6.996E-10	267
LOKIASV2_1322_ESMFold_hypothetical_protein	3vud-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3vud-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1	0.156	320	262	164	474	1	320	2.755E-10	267
LOKIASV2_1322_ESMFold_hypothetical_protein	1gij-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1gij-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR	0.182	293	209	176	468	4	260	5.268E-09	266
LOKIASV2_1322_ESMFold_hypothetical_protein	5fqd-assembly1.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	5fqd-assembly1.cif.gz_C Structural basis of Lenalidomide induced CK1a degradation by the crl4crbn ubiquitin ligase	0.153	306	235	169	474	2	280	4.067E-09	266
LOKIASV2_1322_ESMFold_hypothetical_protein	3rpv-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3rpv-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-88	0.168	292	228	176	467	4	278	6.153E-09	266
LOKIASV2_1322_ESMFold_hypothetical_protein	4tyh-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4tyh-assembly1.cif.gz_A Ternary complex of P38 and MK2 with a P38 inhibitor	0.193	315	215	162	476	1	268	9.545E-10	266
LOKIASV2_1322_ESMFold_hypothetical_protein	7z5n-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7z5n-assembly2.cif.gz_B Crystal structure of DYRK1A in complex with CX-4945	0.163	324	254	163	467	15	338	3.306E-09	266
LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly1.cif.gz_A Phosphorylated p38 and MAPKAPK2 complex with inhibitor	0.188	324	227	162	485	1	280	2.359E-10	266
LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly1.cif.gz_A Crystal structure of SRPK2 in complex with compound 1	0.149	342	260	163	469	4	345	1.115E-09	266
LOKIASV2_1322_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A Complex of Aurora-A bound to an Imidazopyridine-based inhibitor	0.159	300	200	169	468	3	241	3.396E-08	265
LOKIASV2_1322_ESMFold_hypothetical_protein	2cn5-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	2cn5-assembly1.cif.gz_A-2 Crystal structure of human Chk2 in complex with ADP	0.195	307	217	176	482	13	283	3.139E-09	265
LOKIASV2_1322_ESMFold_hypothetical_protein	6yl6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6yl6-assembly1.cif.gz_A Cdk2(F80C)	0.178	291	228	176	466	9	286	2.075E-09	265
LOKIASV2_1322_ESMFold_hypothetical_protein	8buc-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8buc-assembly1.cif.gz_B Structure of DDB1 bound to dCeMM3-engaged CDK12-cyclin K	0.160	292	243	176	467	13	302	3.306E-09	265
LOKIASV2_1322_ESMFold_hypothetical_protein	5vhb-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5vhb-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitor	0.138	320	246	154	473	7	292	1.871E-09	265
LOKIASV2_1322_ESMFold_hypothetical_protein	6l23-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6l23-assembly1.cif.gz_A Crystal structure of CK2a1 V116I with hematein	0.157	304	249	176	479	38	333	6.480E-09	265
LOKIASV2_1322_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.166	325	239	151	475	51	338	6.480E-09	265
LOKIASV2_1322_ESMFold_hypothetical_protein	4wot-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4wot-assembly2.cif.gz_D ROCK2 IN COMPLEX WITH 1426382-07-1	0.168	325	242	151	475	51	342	3.862E-09	265
LOKIASV2_1322_ESMFold_hypothetical_protein	3ma6-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3ma6-assembly2.cif.gz_B Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	0.177	295	213	176	470	6	265	6.825E-09	264
LOKIASV2_1322_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A CDK2 with compound 14 inhibitor with carboxylate	0.175	294	219	176	469	4	269	3.862E-09	264
LOKIASV2_1322_ESMFold_hypothetical_protein	1di8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1di8-assembly1.cif.gz_A THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE	0.177	294	220	176	469	4	271	2.831E-09	264
LOKIASV2_1322_ESMFold_hypothetical_protein	5iey-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5iey-assembly1.cif.gz_A Crystal structure of a CDK inhibitor bound to CDK2	0.168	295	224	176	470	4	273	5.843E-09	264
LOKIASV2_1322_ESMFold_hypothetical_protein	6b3e-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6b3e-assembly2.cif.gz_C Crystal structure of human CDK12/CyclinK in complex with an inhibitor	0.164	294	232	176	469	9	287	4.283E-09	264
LOKIASV2_1322_ESMFold_hypothetical_protein	6dd4-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6dd4-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	0.134	304	253	163	466	2	294	5.268E-09	264
LOKIASV2_1322_ESMFold_hypothetical_protein	6gih-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6gih-assembly1.cif.gz_A Crystal Structure of CK2alpha with CAM187 bound	0.135	308	250	163	470	29	318	3.139E-09	264
LOKIASV2_1322_ESMFold_hypothetical_protein	5n3b-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5n3b-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-(pyridin-3-yl)ethanamine	0.136	313	237	164	476	30	304	1.970E-09	264
LOKIASV2_1322_ESMFold_hypothetical_protein	7p7g-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7p7g-assembly2.cif.gz_B Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 2 and 3	0.155	299	228	176	474	3	273	1.825E-08	263
LOKIASV2_1322_ESMFold_hypothetical_protein	5okt-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5okt-assembly1.cif.gz_A Crystal structure of human Casein Kinase I delta in complex with IWP-2	0.163	299	223	176	474	6	273	8.395E-09	263
LOKIASV2_1322_ESMFold_hypothetical_protein	1xkk-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1xkk-assembly1.cif.gz_A EGFR kinase domain complexed with a quinazoline inhibitor- GW572016	0.166	303	209	168	470	5	255	3.225E-08	263
LOKIASV2_1322_ESMFold_hypothetical_protein	1g3n-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1g3n-assembly1.cif.gz_A STRUCTURE OF A P18(INK4C)-CDK6-K-CYCLIN TERNARY COMPLEX	0.178	292	233	176	467	5	288	1.871E-09	263
LOKIASV2_1322_ESMFold_hypothetical_protein	6una-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6una-assembly2.cif.gz_B Crystal structure of inactive p38gamma	0.161	324	252	162	485	2	302	5.128E-10	263
LOKIASV2_1322_ESMFold_hypothetical_protein	2oza-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2oza-assembly1.cif.gz_A Structure of p38alpha complex	0.196	315	217	162	476	1	271	2.688E-09	263
LOKIASV2_1322_ESMFold_hypothetical_protein	6a1c-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6a1c-assembly1.cif.gz_A Crystal structure of the CK2a1-go289 complex	0.151	304	250	176	479	38	333	5.548E-09	263
LOKIASV2_1322_ESMFold_hypothetical_protein	7pqs-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7pqs-assembly2.cif.gz_B SRPK1 in complex with MSC2711186	0.136	344	265	163	470	5	348	1.005E-09	263
LOKIASV2_1322_ESMFold_hypothetical_protein	1q8y-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1q8y-assembly2.cif.gz_B The structure of the yeast SR protein kinase, Sky1p, with bound ADP	0.152	299	220	163	461	2	262	3.306E-09	263
LOKIASV2_1322_ESMFold_hypothetical_protein	5u7q-assembly6.cif.gz_D-3	LOKIASV2_1322_ESMFold_hypothetical_protein	5u7q-assembly6.cif.gz_D-3 Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	0.153	335	255	151	485	47	348	4.510E-09	263
LOKIASV2_1322_ESMFold_hypothetical_protein	4uyn-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4uyn-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.152	306	205	163	468	1	243	2.364E-08	262
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_C MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	0.184	326	216	160	485	5	270	2.552E-09	262
LOKIASV2_1322_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent ligand at F80C	0.181	294	225	176	469	3	278	3.306E-09	262
LOKIASV2_1322_ESMFold_hypothetical_protein	1bl6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1bl6-assembly1.cif.gz_A THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995	0.153	322	265	163	484	2	315	7.554E-11	262
LOKIASV2_1322_ESMFold_hypothetical_protein	6sgk-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6sgk-assembly1.cif.gz_A Nek2 kinase bound to inhibitor 102	0.168	286	191	176	461	6	235	7.971E-09	261
LOKIASV2_1322_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	0.153	300	211	169	468	1	250	5.548E-09	261
LOKIASV2_1322_ESMFold_hypothetical_protein	6vc0-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6vc0-assembly1.cif.gz_A Crystal structure of the horse MLKL pseudokinase domain	0.137	292	224	176	467	10	270	2.024E-08	261
LOKIASV2_1322_ESMFold_hypothetical_protein	8p7j-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8p7j-assembly2.cif.gz_B Crystal structure of MAP2K6 with a covalent compound GCL96	0.174	301	223	169	469	4	274	6.825E-09	261
LOKIASV2_1322_ESMFold_hypothetical_protein	1buh-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1buh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1	0.171	297	225	171	467	4	275	5.548E-09	261
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_H	LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_H MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	0.190	324	219	162	485	4	274	1.871E-09	261
LOKIASV2_1322_ESMFold_hypothetical_protein	4dgl-assembly1.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4dgl-assembly1.cif.gz_D Crystal Structure of the CK2 Tetrameric Holoenzyme	0.146	325	259	158	482	25	328	6.825E-09	261
LOKIASV2_1322_ESMFold_hypothetical_protein	3f88-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3f88-assembly2.cif.gz_B glycogen synthase Kinase 3beta inhibitor complex	0.181	290	224	174	463	20	293	7.569E-09	261
LOKIASV2_1322_ESMFold_hypothetical_protein	4xhg-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4xhg-assembly1.cif.gz_A Structure of C. glabrata Hrr25 bound to ADP (formate condition)	0.150	310	238	169	478	2	282	8.395E-09	261
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.157	335	253	151	485	51	351	4.510E-09	261
LOKIASV2_1322_ESMFold_hypothetical_protein	4yuq-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4yuq-assembly1.cif.gz_A CDPK1 from Eimeria tenella in complex with inhibitor UW1354	0.171	299	212	169	467	15	271	4.067E-09	261
LOKIASV2_1322_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_A ASK1 kinase domain in complex with GS-4997	0.161	304	180	160	463	2	216	2.622E-08	260
LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.195	287	192	176	462	8	246	7.569E-09	260
LOKIASV2_1322_ESMFold_hypothetical_protein	2wtv-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2wtv-assembly2.cif.gz_B Aurora-A Inhibitor Structure	0.165	302	212	169	470	3	257	7.569E-09	260
LOKIASV2_1322_ESMFold_hypothetical_protein	3le6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3le6-assembly1.cif.gz_A The structure of cyclin dependent kinase 2 (CKD2) with a pyrazolobenzodiazepine inhibitor	0.167	295	225	176	470	4	274	7.569E-09	260
LOKIASV2_1322_ESMFold_hypothetical_protein	2ycf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2ycf-assembly1.cif.gz_A Crystal Structure of Checkpoint Kinase 2 in complex with Inhibitor PV1531	0.197	310	218	176	485	11	282	1.115E-09	260
LOKIASV2_1322_ESMFold_hypothetical_protein	3g33-assembly1.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	3g33-assembly1.cif.gz_C Crystal structure of CDK4/cyclin D3	0.174	295	238	176	470	2	290	1.087E-08	260
LOKIASV2_1322_ESMFold_hypothetical_protein	6rcg-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6rcg-assembly1.cif.gz_A Crystal structure of Casein kinase 1 delta (CK1 delta) complexed with SR3029 inhibitor	0.151	312	239	163	474	2	283	1.645E-08	260
LOKIASV2_1322_ESMFold_hypothetical_protein	5clp-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5clp-assembly1.cif.gz_A Crystal Structure of CK2alpha with 3,4-dichlorophenethylamine bound	0.159	295	235	176	470	37	316	7.569E-09	260
LOKIASV2_1322_ESMFold_hypothetical_protein	5my8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5my8-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with SPHINX31	0.133	346	266	163	470	7	352	1.005E-09	260
LOKIASV2_1322_ESMFold_hypothetical_protein	5o2c-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5o2c-assembly1.cif.gz_A Crystal structure of WNK3 kinase and CCT1 didomain in a unphosphorylated state	0.162	316	225	176	491	18	287	1.776E-09	260
LOKIASV2_1322_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_B Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	0.163	335	249	151	485	53	351	4.283E-09	260
LOKIASV2_1322_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_C Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	0.182	297	206	169	465	2	254	2.024E-08	259
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_C Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	0.188	322	214	163	484	2	265	8.841E-09	259
LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_C Crystal Structure of Domain-Swapped OSR1 kinase domain	0.148	292	227	176	467	11	278	3.862E-09	259
LOKIASV2_1322_ESMFold_hypothetical_protein	7nzy-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	7nzy-assembly4.cif.gz_D Crystal structure of human Casein Kinase I delta in complex with CGS-15943	0.157	306	228	169	474	1	272	1.562E-08	259
LOKIASV2_1322_ESMFold_hypothetical_protein	7p7f-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	7p7f-assembly3.cif.gz_C Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 1	0.152	299	226	176	474	6	272	2.131E-08	259
LOKIASV2_1322_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B Crystal Structure of the Human Ribosomal protein S6 kinase	0.156	295	208	176	470	4	250	5.548E-09	259
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_I	LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_I MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	0.174	323	221	163	485	5	273	4.510E-09	259
LOKIASV2_1322_ESMFold_hypothetical_protein	5n1m-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5n1m-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule (5-chloro-2-methoxyphenyl)methanamine	0.146	326	249	151	476	17	309	2.075E-09	259
LOKIASV2_1322_ESMFold_hypothetical_protein	4l6q-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4l6q-assembly1.cif.gz_A ROCK2 in complex with benzoxaborole	0.157	335	256	151	485	47	351	5.002E-09	259
LOKIASV2_1322_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_B ROCK 1 bound to a pyridine thiazole inhibitor	0.160	335	255	151	485	53	357	6.480E-09	259
LOKIASV2_1322_ESMFold_hypothetical_protein	3dbe-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3dbe-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 557	0.152	324	234	163	486	1	277	1.145E-08	258
LOKIASV2_1322_ESMFold_hypothetical_protein	5ouu-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5ouu-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 22	0.150	321	264	150	470	8	319	6.825E-09	258
LOKIASV2_1322_ESMFold_hypothetical_protein	4wbo-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4wbo-assembly2.cif.gz_B Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.137	307	243	176	482	158	440	3.862E-09	258
LOKIASV2_1322_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	0.175	273	191	176	448	5	237	4.633E-08	257
LOKIASV2_1322_ESMFold_hypothetical_protein	4kb8-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4kb8-assembly3.cif.gz_C CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand	0.157	299	221	176	474	3	265	1.145E-08	257
LOKIASV2_1322_ESMFold_hypothetical_protein	1oir-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1oir-assembly1.cif.gz_A Imidazopyridines: a potent and selective class of Cyclin-dependent Kinase inhibitors identified through Structure-based hybridisation	0.175	292	222	176	467	4	273	2.423E-09	257
LOKIASV2_1322_ESMFold_hypothetical_protein	3v04-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3v04-assembly1.cif.gz_A Discovery of Novel Allosteric MEK Inhibitors Possessing Classical and Non-classical Bidentate Ser212 Interactions.	0.183	311	233	169	479	3	288	2.423E-09	257
LOKIASV2_1322_ESMFold_hypothetical_protein	3s0o-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3s0o-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-1-138	0.174	294	229	176	469	4	281	7.971E-09	257
LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly3.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly3.cif.gz_E Phosphorylated p38 and MAPKAPK2 complex with inhibitor	0.189	318	213	162	479	1	264	2.185E-09	257
LOKIASV2_1322_ESMFold_hypothetical_protein	1rdq-assembly1.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	1rdq-assembly1.cif.gz_E Hydrolysis of ATP in the crystal of Y204A mutant of cAMP-dependent protein kinase	0.140	329	238	154	482	16	293	3.482E-09	257
LOKIASV2_1322_ESMFold_hypothetical_protein	2vo0-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2vo0-assembly1.cif.gz_A Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-yl)methylamine	0.140	325	256	146	470	4	302	4.283E-09	257
LOKIASV2_1322_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_A Crystal Structure of PF11_0147	0.171	317	257	154	470	5	315	5.990E-10	257
LOKIASV2_1322_ESMFold_hypothetical_protein	7jnt-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7jnt-assembly1.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.154	335	245	151	485	51	341	5.002E-09	257
LOKIASV2_1322_ESMFold_hypothetical_protein	3mwu-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3mwu-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor RM-1-95	0.170	306	227	176	481	11	284	3.862E-09	257
LOKIASV2_1322_ESMFold_hypothetical_protein	1muo-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1muo-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE	0.166	293	201	169	461	1	242	1.645E-08	256
LOKIASV2_1322_ESMFold_hypothetical_protein	6vpm-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6vpm-assembly1.cif.gz_B TPX2 residues 7-20 fused to Aurora A residues 116-389 with C290 disulfide bonded to compound 8-34, and in complex with AMP-PNP	0.165	301	210	169	469	20	271	5.548E-09	256
LOKIASV2_1322_ESMFold_hypothetical_protein	7vto-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7vto-assembly2.cif.gz_B The crystal structure of PAK1 with the inhibitor GW8510	0.152	302	219	180	481	20	278	7.569E-09	256
LOKIASV2_1322_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8	LOKIASV2_1322_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8 TFIID-based holo PIC on SCP promoter	0.162	292	230	176	467	3	277	6.480E-09	256
LOKIASV2_1322_ESMFold_hypothetical_protein	2xh5-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2xh5-assembly1.cif.gz_A Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to PKB	0.147	302	223	169	470	2	263	1.922E-08	256
LOKIASV2_1322_ESMFold_hypothetical_protein	4wua-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4wua-assembly1.cif.gz_A Crystal structure of human SRPK1 complexed to an inhibitor SRPIN340	0.135	340	266	163	470	2	341	3.139E-09	256
LOKIASV2_1322_ESMFold_hypothetical_protein	6ed6-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6ed6-assembly2.cif.gz_B Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor	0.162	335	239	151	485	46	331	6.153E-09	256
LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly4.cif.gz_G	LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly4.cif.gz_G CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.184	316	230	169	484	1	283	6.480E-09	256
LOKIASV2_1322_ESMFold_hypothetical_protein	2w96-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2w96-assembly1.cif.gz_B Crystal Structure of CDK4 in complex with a D-type cyclin	0.192	295	213	176	470	3	266	3.767E-08	255
LOKIASV2_1322_ESMFold_hypothetical_protein	5mqv-assembly6.cif.gz_F	LOKIASV2_1322_ESMFold_hypothetical_protein	5mqv-assembly6.cif.gz_F Crystal structure of human Casein Kinase I delta in complex with 4-(2,5-Dimethoxyphenyl)-N-(4-(5-(4-fluorphenyl)-2-(methylthio)-1H-imidazol-4-yl)-pyridin-2-yl)-1-methyl-1H-pyrrole-2-carboxamide	0.151	307	233	176	482	3	277	1.338E-08	255
LOKIASV2_1322_ESMFold_hypothetical_protein	3uyt-assembly6.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	3uyt-assembly6.cif.gz_C crystal structure of ck1d with PF670462 from P1 crystal form	0.170	307	225	176	482	6	277	8.841E-09	255
LOKIASV2_1322_ESMFold_hypothetical_protein	2yir-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2yir-assembly1.cif.gz_A Structural analysis of checkpoint kinase 2 in complex with inhibitor PV1352	0.202	310	217	176	485	11	283	1.521E-09	255
LOKIASV2_1322_ESMFold_hypothetical_protein	7b3m-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7b3m-assembly2.cif.gz_B MEK1 in complex with compound 6	0.180	324	234	151	474	12	297	6.825E-09	255
LOKIASV2_1322_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MICROTUBULE AFFINITY-REGULATING KINASE 4 CATALYTIC DOMAIN IN COMPLEX WITH A PYRAZOLOPYRIMIDINE INHIBITOR	0.156	293	204	176	468	6	248	1.825E-08	255
LOKIASV2_1322_ESMFold_hypothetical_protein	6buu-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6buu-assembly1.cif.gz_A Crystal structure of AKT1 (aa 144-480) with a bisubstrate	0.153	310	235	176	485	7	285	1.825E-08	255
LOKIASV2_1322_ESMFold_hypothetical_protein	5czo-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5czo-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	0.155	312	237	168	479	3	283	3.862E-09	255
LOKIASV2_1322_ESMFold_hypothetical_protein	3tv7-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3tv7-assembly1.cif.gz_A Human Rho-associated protein kinase 1 (ROCK 1) in COMPLEX WITH RKI1342	0.166	335	254	151	485	49	353	5.002E-09	255
LOKIASV2_1322_ESMFold_hypothetical_protein	4mvf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4mvf-assembly1.cif.gz_A Crystal Structure of Plasmodium falciparum CDPK2 complexed with inhibitor staurosporine	0.170	321	198	163	483	1	240	6.825E-09	255
LOKIASV2_1322_ESMFold_hypothetical_protein	3efw-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3efw-assembly1.cif.gz_A Structure of AuroraA with pyridyl-pyrimidine urea inhibitor	0.144	300	200	169	468	3	237	5.412E-08	254
LOKIASV2_1322_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_B Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	0.164	276	202	176	451	4	246	6.002E-08	254
LOKIASV2_1322_ESMFold_hypothetical_protein	4kbk-assembly5.cif.gz_B-2	LOKIASV2_1322_ESMFold_hypothetical_protein	4kbk-assembly5.cif.gz_B-2 CK1d in complex with (3S)-3-{4-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]pyridin-2-yl}morpholine inhibitor	0.161	306	232	169	474	1	277	2.245E-08	254
LOKIASV2_1322_ESMFold_hypothetical_protein	6cfm-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6cfm-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a propynyl-pteridinone inhibitor	0.133	304	255	163	466	2	296	1.409E-08	254
LOKIASV2_1322_ESMFold_hypothetical_protein	2h6d-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2h6d-assembly1.cif.gz_A Protein Kinase Domain of the Human 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK alpha-2 chain)	0.154	299	207	169	467	2	247	3.577E-08	253
LOKIASV2_1322_ESMFold_hypothetical_protein	3d5v-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3d5v-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain.	0.137	299	200	164	462	1	233	6.657E-08	253
LOKIASV2_1322_ESMFold_hypothetical_protein	2b55-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2b55-assembly1.cif.gz_A Human cyclin dependent kinase 2 (cdk2) complexed with indenopyraxole DIN-101312	0.169	291	212	176	466	4	259	1.562E-08	253
LOKIASV2_1322_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_B Crystal structure of murine SPAK(T243D) in complex with AMPPNP	0.169	309	230	169	477	4	281	4.510E-09	253
LOKIASV2_1322_ESMFold_hypothetical_protein	7wtt-assembly1.cif.gz_a	LOKIASV2_1322_ESMFold_hypothetical_protein	7wtt-assembly1.cif.gz_a Cryo-EM structure of a human pre-40S ribosomal subunit - State RRP12-A1 (with CK1)	0.153	317	239	169	485	3	285	9.310E-09	253
LOKIASV2_1322_ESMFold_hypothetical_protein	3n9x-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3n9x-assembly1.cif.gz_A Crystal structure of Map Kinase from plasmodium berghei, PB000659.00.0	0.151	306	255	169	469	12	317	2.423E-09	253
LOKIASV2_1322_ESMFold_hypothetical_protein	7ejv-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7ejv-assembly1.cif.gz_A The co-crystal structure of DYRK2 with YK-2-69	0.165	311	245	176	470	72	382	3.139E-09	253
LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly1.cif.gz_A CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.192	316	227	169	484	1	282	4.067E-09	253
LOKIASV2_1322_ESMFold_hypothetical_protein	3o50-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3o50-assembly1.cif.gz_A Crystal structure of benzamide 9 bound to AuroraA	0.159	302	199	169	470	3	240	3.577E-08	252
LOKIASV2_1322_ESMFold_hypothetical_protein	3ocb-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3ocb-assembly2.cif.gz_B Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.160	309	234	176	484	7	285	7.569E-09	252
LOKIASV2_1322_ESMFold_hypothetical_protein	1ctp-assembly1.cif.gz_E-2	LOKIASV2_1322_ESMFold_hypothetical_protein	1ctp-assembly1.cif.gz_E-2 STRUCTURE OF THE MAMMALIAN CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE AND AN INHIBITOR PEPTIDE DISPLAYS AN OPEN CONFORMATION	0.162	316	229	154	469	18	291	7.971E-09	252
LOKIASV2_1322_ESMFold_hypothetical_protein	5n1o-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5n1o-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-chloro-4-(chloromethyl)-5-hydroxyphenyl)ethan-1-one	0.138	310	234	167	476	26	298	6.153E-09	252
LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H	LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.186	286	198	176	461	7	250	1.484E-08	251
LOKIASV2_1322_ESMFold_hypothetical_protein	3dbf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3dbf-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 562	0.137	305	209	163	467	1	243	1.374E-07	251
LOKIASV2_1322_ESMFold_hypothetical_protein	2w4o-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2w4o-assembly1.cif.gz_A Crystal structure of Human CAMK4 in complex with 4-Amino(sulfamoyl- phenylamino)-triazole-carbothioic acid (2,6-difluoro-phenyl)-amide)	0.150	321	235	163	483	1	278	1.484E-08	251
LOKIASV2_1322_ESMFold_hypothetical_protein	4xbr-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4xbr-assembly1.cif.gz_A In cellulo Crystal Structure of PAK4 in complex with Inka	0.131	287	215	181	467	53	300	9.082E-08	251
LOKIASV2_1322_ESMFold_hypothetical_protein	4h3p-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4h3p-assembly2.cif.gz_D Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.159	306	240	176	481	15	300	1.871E-09	251
LOKIASV2_1322_ESMFold_hypothetical_protein	1lew-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1lew-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A	0.146	318	256	167	484	5	305	4.391E-10	251
LOKIASV2_1322_ESMFold_hypothetical_protein	3n9x-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3n9x-assembly1.cif.gz_B Crystal structure of Map Kinase from plasmodium berghei, PB000659.00.0	0.170	315	259	169	483	13	325	1.302E-09	251
LOKIASV2_1322_ESMFold_hypothetical_protein	5wnh-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	5wnh-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.159	335	247	151	485	54	348	8.395E-09	251
LOKIASV2_1322_ESMFold_hypothetical_protein	4wbo-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4wbo-assembly3.cif.gz_C Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.145	309	243	176	484	157	441	9.310E-09	251
LOKIASV2_1322_ESMFold_hypothetical_protein	2bal-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2bal-assembly1.cif.gz_A p38alpha MAP kinase bound to pyrazoloamine	0.155	318	251	167	484	5	302	8.606E-10	250
LOKIASV2_1322_ESMFold_hypothetical_protein	3n51-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3n51-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor RM-1-95	0.188	311	222	169	479	1	274	9.310E-09	250
LOKIASV2_1322_ESMFold_hypothetical_protein	4rvt-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4rvt-assembly1.cif.gz_A MAP4K4 in complex with a pyridin-2(1H)-one derivative	0.143	300	230	176	475	12	280	3.767E-08	249
LOKIASV2_1322_ESMFold_hypothetical_protein	2w9z-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2w9z-assembly1.cif.gz_B Crystal Structure of CDK4 in complex with a D-type cyclin	0.172	295	233	176	470	5	286	2.622E-08	249
LOKIASV2_1322_ESMFold_hypothetical_protein	3e8n-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3e8n-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) complexed with a potent inhibitor RDEA119 and MgATP	0.163	306	239	169	474	3	289	9.805E-09	249
LOKIASV2_1322_ESMFold_hypothetical_protein	5osj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5osj-assembly1.cif.gz_A Cdk2(WT) with covalent adduct at C177	0.183	295	227	176	470	3	281	2.423E-09	249
LOKIASV2_1322_ESMFold_hypothetical_protein	3o71-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3o71-assembly1.cif.gz_A Crystal structure of ERK2/DCC peptide complex	0.160	295	240	176	470	15	301	2.981E-09	249
LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_C-3	LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_C-3 ROCK2 IN COMPLEX WITH COMPOUND 12	0.154	335	247	151	485	51	343	1.087E-08	249
LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH COMPOUND 12	0.155	335	250	151	485	49	345	8.395E-09	249
LOKIASV2_1322_ESMFold_hypothetical_protein	4uak-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	4uak-assembly1.cif.gz_A-2 MRCK beta in complex with ADP	0.140	325	251	151	475	62	354	2.245E-08	249
LOKIASV2_1322_ESMFold_hypothetical_protein	4wbo-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4wbo-assembly4.cif.gz_D Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.145	307	241	176	482	153	435	5.002E-09	249
LOKIASV2_1322_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.155	294	204	169	462	2	243	7.775E-08	248
LOKIASV2_1322_ESMFold_hypothetical_protein	1zxe-assembly3.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	1zxe-assembly3.cif.gz_E Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.187	294	198	169	462	2	245	6.657E-08	248
LOKIASV2_1322_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A Crystal Structure of Human Serine Threonine Kinase-10 (LOK) Bound to GW830263A	0.159	302	216	176	477	21	278	7.011E-08	248
LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_A Crystal Structure of Domain-Swapped OSR1 kinase domain	0.161	291	222	176	466	12	277	1.409E-08	248
LOKIASV2_1322_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23 T190D mutant	0.166	293	212	176	468	11	265	1.922E-08	248
LOKIASV2_1322_ESMFold_hypothetical_protein	3vvh-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3vvh-assembly2.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in complex with an inhibitor and MgATP	0.181	306	233	169	474	3	288	1.562E-08	248
LOKIASV2_1322_ESMFold_hypothetical_protein	4e73-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4e73-assembly1.cif.gz_A Crystal structure of JNK1beta-JIP in complex with an azaquinolone inhbitor	0.155	319	249	164	482	1	296	5.548E-09	248
LOKIASV2_1322_ESMFold_hypothetical_protein	8aco-assembly1.cif.gz_AAA	LOKIASV2_1322_ESMFold_hypothetical_protein	8aco-assembly1.cif.gz_AAA Crystal structure of WT p38alpha	0.152	322	254	163	484	1	300	8.172E-10	248
LOKIASV2_1322_ESMFold_hypothetical_protein	6sou-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6sou-assembly1.cif.gz_A Fragment N13565a in complex with MAP kinase p38-alpha	0.143	308	258	163	470	1	302	3.759E-10	248
LOKIASV2_1322_ESMFold_hypothetical_protein	1xha-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1xha-assembly1.cif.gz_A Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mutants	0.150	329	235	154	482	24	301	1.059E-09	248
LOKIASV2_1322_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.150	325	226	151	475	49	315	1.733E-08	248
LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_H-2	LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_H-2 ROCK2 IN COMPLEX WITH COMPOUND 12	0.159	325	227	151	475	49	319	1.645E-08	248
LOKIASV2_1322_ESMFold_hypothetical_protein	4fi1-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4fi1-assembly1.cif.gz_A Crystal structure of scCK2 alpha in complex with ATP	0.133	332	262	176	478	40	371	2.552E-09	248
LOKIASV2_1322_ESMFold_hypothetical_protein	3c4x-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3c4x-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.9A	0.146	307	241	176	482	149	431	1.033E-08	248
LOKIASV2_1322_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_B Crystal structure of STING CTD in complex with TBK1	0.143	310	262	165	471	1	310	1.922E-08	248
LOKIASV2_1322_ESMFold_hypothetical_protein	2yza-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2yza-assembly1.cif.gz_A Crystal structure of kinase domain of Human 5'-AMP-activated protein kinase alpha-2 subunit mutant (T172D)	0.154	294	203	169	462	2	242	6.657E-08	247
LOKIASV2_1322_ESMFold_hypothetical_protein	8guw-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8guw-assembly1.cif.gz_A Structure of Aurora Kinase A in complex with activator peptide	0.158	321	226	150	470	8	276	2.423E-09	247
LOKIASV2_1322_ESMFold_hypothetical_protein	4h3p-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4h3p-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.167	309	242	176	484	15	306	2.688E-09	247
LOKIASV2_1322_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_D Crystal structure of the kinase domain of CIPK23	0.171	310	225	161	470	1	272	1.145E-08	246
LOKIASV2_1322_ESMFold_hypothetical_protein	5cvf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5cvf-assembly1.cif.gz_A Crystal Structure of CK2alpha with Compound 5 bound	0.151	307	248	164	470	27	319	2.908E-08	246
LOKIASV2_1322_ESMFold_hypothetical_protein	1xh9-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1xh9-assembly1.cif.gz_A Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mutants	0.157	333	237	150	482	8	289	5.548E-09	246
LOKIASV2_1322_ESMFold_hypothetical_protein	1apm-assembly1.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	1apm-assembly1.cif.gz_E 2.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT	0.142	323	244	154	476	15	299	1.087E-08	246
LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_A ROCK2 IN COMPLEX WITH COMPOUND 12	0.160	335	250	151	485	50	348	1.645E-08	246
LOKIASV2_1322_ESMFold_hypothetical_protein	3ncg-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3ncg-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor NM-PP1	0.183	299	211	170	468	6	264	1.338E-08	246
LOKIASV2_1322_ESMFold_hypothetical_protein	8cav-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8cav-assembly1.cif.gz_A Discovery of the lanthipeptide Curvocidin and structural insights into its trifunctional synthetase CuvL	0.148	307	225	162	468	199	463	1.484E-08	246
LOKIASV2_1322_ESMFold_hypothetical_protein	7b9l-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7b9l-assembly1.cif.gz_A MEK1 in complex with compound 23	0.178	324	231	151	474	16	297	1.484E-08	245
LOKIASV2_1322_ESMFold_hypothetical_protein	7b3m-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7b3m-assembly1.cif.gz_A MEK1 in complex with compound 6	0.180	323	232	151	473	16	299	7.569E-09	245
LOKIASV2_1322_ESMFold_hypothetical_protein	5cs6-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5cs6-assembly2.cif.gz_B Crystal Structure of CK2alpha with Compound 3 bound	0.152	319	258	152	470	8	312	2.490E-08	245
LOKIASV2_1322_ESMFold_hypothetical_protein	6una-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6una-assembly1.cif.gz_A Crystal structure of inactive p38gamma	0.171	322	248	162	483	1	300	1.371E-09	245
LOKIASV2_1322_ESMFold_hypothetical_protein	2gu8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2gu8-assembly1.cif.gz_A Discovery of 2-Pyrimidyl-5-Amidothiophenes as Novel and Potent Inhibitors for AKT: Synthesis and SAR Studies	0.130	331	258	154	484	11	307	3.139E-09	245
LOKIASV2_1322_ESMFold_hypothetical_protein	4wb6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4wb6-assembly1.cif.gz_A Crystal structure of a L205R mutant of human cAMP-dependent protein kinase A (catalytic alpha subunit)	0.136	333	255	154	486	12	307	4.067E-09	245
LOKIASV2_1322_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_B ROCK 1 bound to methoxyphenyl thiazole inhibitor	0.161	335	255	151	485	53	357	2.131E-08	245
LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly2.cif.gz_B GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.183	288	195	176	463	8	247	3.396E-08	244
LOKIASV2_1322_ESMFold_hypothetical_protein	8guw-assembly1.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	8guw-assembly1.cif.gz_C Structure of Aurora Kinase A in complex with activator peptide	0.148	320	216	151	470	11	264	2.245E-08	244
LOKIASV2_1322_ESMFold_hypothetical_protein	7pvu-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7pvu-assembly1.cif.gz_A Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1	0.152	318	252	167	484	5	302	9.545E-10	244
LOKIASV2_1322_ESMFold_hypothetical_protein	3zo4-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3zo4-assembly1.cif.gz_A The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors	0.136	331	256	154	484	11	307	3.139E-09	244
LOKIASV2_1322_ESMFold_hypothetical_protein	5r96-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5r96-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL095 in complex with MAP kinase p38-alpha	0.159	318	259	167	484	5	313	5.401E-10	244
LOKIASV2_1322_ESMFold_hypothetical_protein	3qam-assembly1.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	3qam-assembly1.cif.gz_E Crystal Structure of Glu208Ala mutant of catalytic subunit of cAMP-dependent protein kinase	0.125	333	258	154	486	24	319	1.521E-09	244
LOKIASV2_1322_ESMFold_hypothetical_protein	5wne-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	5wne-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.156	335	249	151	485	54	349	9.805E-09	244
LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly4.cif.gz_G-5	LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly4.cif.gz_G-5 ROCK2 IN COMPLEX WITH COMPOUND 12	0.162	335	251	151	485	49	349	2.024E-08	244
LOKIASV2_1322_ESMFold_hypothetical_protein	1zyc-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1zyc-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	0.194	294	197	169	462	2	247	7.383E-08	243
LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_B Crystal Structure of Domain-Swapped OSR1 kinase domain	0.156	291	223	176	466	12	276	3.062E-08	243
LOKIASV2_1322_ESMFold_hypothetical_protein	3uvq-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3uvq-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative	0.146	308	249	163	470	1	292	5.548E-09	243
LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly4.cif.gz_G	LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly4.cif.gz_G Phosphorylated p38 and MAPKAPK2 complex with inhibitor	0.186	318	220	162	479	1	271	5.548E-09	243
LOKIASV2_1322_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	0.179	292	212	176	467	18	276	1.033E-08	242
LOKIASV2_1322_ESMFold_hypothetical_protein	7b94-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7b94-assembly1.cif.gz_A MEK1 in complex with compound 6	0.170	324	235	151	474	16	299	9.805E-09	242
LOKIASV2_1322_ESMFold_hypothetical_protein	6ncg-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6ncg-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to pyridin-benzenesulfonamide inhibitor	0.128	305	256	163	467	2	296	9.805E-09	242
LOKIASV2_1322_ESMFold_hypothetical_protein	5ukf-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	5ukf-assembly3.cif.gz_C Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	0.137	304	256	163	466	3	300	7.569E-09	242
LOKIASV2_1322_ESMFold_hypothetical_protein	3op5-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3op5-assembly1.cif.gz_A Human vaccinia-related kinase 1	0.134	304	260	163	466	3	303	9.310E-09	242
LOKIASV2_1322_ESMFold_hypothetical_protein	5otl-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5otl-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 29	0.146	319	263	152	470	8	316	2.490E-08	242
LOKIASV2_1322_ESMFold_hypothetical_protein	4r3c-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4r3c-assembly1.cif.gz_A Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate	0.149	322	255	163	484	2	302	1.444E-09	242
LOKIASV2_1322_ESMFold_hypothetical_protein	1q24-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1q24-assembly1.cif.gz_A PKA double mutant model of PKB in complex with MgATP	0.145	329	237	154	482	11	288	8.841E-09	242
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.153	325	226	151	475	49	316	1.562E-08	242
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_K	LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_K Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	0.163	297	196	188	484	29	263	1.562E-08	241
LOKIASV2_1322_ESMFold_hypothetical_protein	3vn9-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3vn9-assembly1.cif.gz_A Rifined Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state	0.152	307	233	169	475	1	276	9.310E-09	241
LOKIASV2_1322_ESMFold_hypothetical_protein	5czo-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5czo-assembly2.cif.gz_B Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	0.156	312	233	168	479	3	279	2.024E-08	241
LOKIASV2_1322_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_B Structure and Activation Mechanism of the CHK2 DNA-Damage Checkpoint Kinase	0.206	294	182	176	469	132	361	2.024E-08	241
LOKIASV2_1322_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_C Crystal Structure of ROCK 1 bound to YB-15-QD37	0.161	335	248	151	485	52	348	3.767E-08	241
LOKIASV2_1322_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_A Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	0.164	335	247	151	485	52	348	3.225E-08	241
LOKIASV2_1322_ESMFold_hypothetical_protein	6cmm-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6cmm-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine inhibitor	0.134	304	257	163	466	1	298	2.908E-08	240
LOKIASV2_1322_ESMFold_hypothetical_protein	5n3d-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5n3d-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 4-(trifluoromethyl)benzenecarboximidamide	0.138	308	233	169	476	38	308	1.033E-08	240
LOKIASV2_1322_ESMFold_hypothetical_protein	2h9v-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2h9v-assembly1.cif.gz_A Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y27632	0.149	325	249	151	475	49	342	2.622E-08	240
LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly2.cif.gz_C CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.184	316	217	169	484	1	267	5.002E-09	240
LOKIASV2_1322_ESMFold_hypothetical_protein	1zxe-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	1zxe-assembly2.cif.gz_C Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.169	314	227	169	482	2	275	7.775E-08	239
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_D Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	0.160	292	199	186	477	26	263	3.062E-08	239
LOKIASV2_1322_ESMFold_hypothetical_protein	8fjz-assembly3.cif.gz_E-2	LOKIASV2_1322_ESMFold_hypothetical_protein	8fjz-assembly3.cif.gz_E-2 Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.175	313	221	167	479	2	270	9.805E-09	239
LOKIASV2_1322_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_A Crystal structure of murine SPAK(T243D) in complex with AMPPNP	0.173	302	227	169	470	4	278	1.206E-08	239
LOKIASV2_1322_ESMFold_hypothetical_protein	7l25-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7l25-assembly2.cif.gz_B HPK1 IN COMPLEX WITH COMPOUND 18	0.185	303	217	165	467	4	270	1.825E-08	239
LOKIASV2_1322_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_B Crystal structure of SPAK (STK39) dimer in the basal activity state	0.174	300	230	176	475	11	290	9.805E-09	239
LOKIASV2_1322_ESMFold_hypothetical_protein	1zz2-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1zz2-assembly1.cif.gz_A Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes	0.150	322	257	163	484	1	303	2.552E-09	239
LOKIASV2_1322_ESMFold_hypothetical_protein	7sxf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7sxf-assembly1.cif.gz_A BIO-2895 (BRD0705) bound GSK3alpha-axin complex	0.185	292	226	175	466	16	293	2.024E-08	239
LOKIASV2_1322_ESMFold_hypothetical_protein	2gnf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2gnf-assembly1.cif.gz_A Protein kinase A fivefold mutant model of Rho-kinase with Y-27632	0.144	329	237	154	482	15	292	1.371E-09	239
LOKIASV2_1322_ESMFold_hypothetical_protein	5bx7-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5bx7-assembly1.cif.gz_A PKA in complex with a benzothiophene fragment compound.	0.131	322	246	154	475	20	303	6.480E-09	239
LOKIASV2_1322_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.168	335	253	151	485	44	348	3.062E-08	239
LOKIASV2_1322_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	0.188	294	197	169	462	2	245	1.974E-07	238
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_B Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	0.164	276	186	188	463	30	252	8.189E-08	238
LOKIASV2_1322_ESMFold_hypothetical_protein	4an9-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4an9-assembly1.cif.gz_A Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs.	0.178	311	226	169	479	6	281	2.245E-08	238
LOKIASV2_1322_ESMFold_hypothetical_protein	4hni-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4hni-assembly2.cif.gz_B crystal structure of ck1e in complex with PF4800567	0.164	316	230	167	482	1	276	2.908E-08	238
LOKIASV2_1322_ESMFold_hypothetical_protein	6ac9-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6ac9-assembly3.cif.gz_C Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP	0.142	303	248	164	466	1	290	3.967E-08	238
LOKIASV2_1322_ESMFold_hypothetical_protein	3eqd-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3eqd-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a binary complex with ATP-GS and MG2P	0.161	324	252	151	474	13	313	5.002E-09	238
LOKIASV2_1322_ESMFold_hypothetical_protein	1syk-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1syk-assembly2.cif.gz_B Crystal structure of E230Q mutant of cAMP-dependent protein kinase reveals unexpected apoenzyme conformation	0.137	323	249	151	473	9	297	7.187E-09	238
LOKIASV2_1322_ESMFold_hypothetical_protein	6yqj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6yqj-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with open-chain Fasudil-derivative 2-[isoquinolin-5-ylsulfonyl(propyl)amino]ethylazanium (soaked)	0.122	308	237	169	476	38	308	1.087E-08	238
LOKIASV2_1322_ESMFold_hypothetical_protein	4iw0-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	4iw0-assembly1.cif.gz_A-2 Crystal structure and mechanism of activation of TBK1	0.150	308	258	167	471	1	308	1.270E-08	238
LOKIASV2_1322_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_F	LOKIASV2_1322_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_F Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	0.170	287	198	176	462	5	243	6.657E-08	237
LOKIASV2_1322_ESMFold_hypothetical_protein	6gtt-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6gtt-assembly1.cif.gz_A Human STK10 bound to BIRB-796	0.154	315	228	164	478	12	281	2.622E-08	237
LOKIASV2_1322_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23	0.166	310	223	176	485	10	277	1.033E-08	237
LOKIASV2_1322_ESMFold_hypothetical_protein	5j5t-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	5j5t-assembly1.cif.gz_A-2 GLK co-crystal structure with aminopyrrolopyrimidine inhibitor	0.183	310	232	176	485	5	289	1.871E-09	237
LOKIASV2_1322_ESMFold_hypothetical_protein	6btw-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6btw-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a phenyl-pteridinone inhibitor	0.131	304	251	163	466	1	290	3.396E-08	237
LOKIASV2_1322_ESMFold_hypothetical_protein	1syk-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1syk-assembly1.cif.gz_A Crystal structure of E230Q mutant of cAMP-dependent protein kinase reveals unexpected apoenzyme conformation	0.131	333	259	154	486	24	322	2.688E-09	237
LOKIASV2_1322_ESMFold_hypothetical_protein	5vib-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5vib-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitors	0.142	322	243	154	475	7	290	1.922E-08	236
LOKIASV2_1322_ESMFold_hypothetical_protein	3ag9-assembly3.cif.gz_B-2	LOKIASV2_1322_ESMFold_hypothetical_protein	3ag9-assembly3.cif.gz_B-2 Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1012	0.146	329	237	154	482	10	287	8.841E-09	236
LOKIASV2_1322_ESMFold_hypothetical_protein	6csw-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6csw-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N-methyl-N-propyl-dihydropteridine inhibitor	0.138	304	257	163	466	4	302	1.645E-08	236
LOKIASV2_1322_ESMFold_hypothetical_protein	5ukf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5ukf-assembly1.cif.gz_A Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	0.135	304	260	163	466	4	305	1.206E-08	236
LOKIASV2_1322_ESMFold_hypothetical_protein	6k0j-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6k0j-assembly1.cif.gz_A The co-crystal structure of DYRK2 with a small molecule inhibitor	0.166	323	256	163	470	1	323	4.400E-08	236
LOKIASV2_1322_ESMFold_hypothetical_protein	2gnj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2gnj-assembly1.cif.gz_A PKA three fold mutant model of Rho-kinase with Y-27632	0.151	329	235	154	482	11	288	3.862E-09	236
LOKIASV2_1322_ESMFold_hypothetical_protein	5wng-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	5wng-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.159	335	248	151	485	54	349	5.139E-08	236
LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G5018	0.160	335	247	151	485	53	347	3.225E-08	236
LOKIASV2_1322_ESMFold_hypothetical_protein	8fh4-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	8fh4-assembly4.cif.gz_D Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-[6-chloro-4-(9-methyl-1-oxa-4,9-diazaspiro[5.5]undec-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile	0.164	292	208	176	467	10	259	2.131E-08	235
LOKIASV2_1322_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_D Crystal structure of the kinase domain of CIPK23 T190D mutant	0.177	305	217	161	465	1	265	3.767E-08	235
LOKIASV2_1322_ESMFold_hypothetical_protein	2w1z-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2w1z-assembly1.cif.gz_A ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	0.120	331	285	152	482	30	354	1.206E-08	235
LOKIASV2_1322_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	0.172	301	222	167	467	1	269	1.409E-08	234
LOKIASV2_1322_ESMFold_hypothetical_protein	7b9l-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7b9l-assembly2.cif.gz_B MEK1 in complex with compound 23	0.180	323	235	151	473	8	294	2.024E-08	234
LOKIASV2_1322_ESMFold_hypothetical_protein	3nx8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3nx8-assembly1.cif.gz_A human cAMP dependent protein kinase in complex with phenol	0.149	323	241	154	476	10	293	6.153E-09	234
LOKIASV2_1322_ESMFold_hypothetical_protein	2qur-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2qur-assembly1.cif.gz_A Crystal Structure of F327A/K285P Mutant of cAMP-dependent Protein Kinase	0.150	332	238	151	482	11	291	7.971E-09	234
LOKIASV2_1322_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	0.115	455	366	167	621	1	414	2.902E-10	234
LOKIASV2_1322_ESMFold_hypothetical_protein	5jn2-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5jn2-assembly1.cif.gz_A Crystal structure of TgCDPK1 bound to NVPACU106	0.185	308	232	169	476	3	288	9.310E-09	234
LOKIASV2_1322_ESMFold_hypothetical_protein	3vw8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3vw8-assembly1.cif.gz_A Crystal structure of human c-Met kinase domain with its inhibitor	0.144	295	217	176	470	38	292	8.624E-08	233
LOKIASV2_1322_ESMFold_hypothetical_protein	3ncz-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	3ncz-assembly2.cif.gz_C X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor	0.160	335	249	151	485	52	349	5.699E-08	233
LOKIASV2_1322_ESMFold_hypothetical_protein	5w91-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5w91-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor LZH118	0.183	308	233	169	476	3	288	1.602E-09	233
LOKIASV2_1322_ESMFold_hypothetical_protein	6dd4-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6dd4-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	0.139	304	256	163	466	3	300	3.577E-08	232
LOKIASV2_1322_ESMFold_hypothetical_protein	6cmm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6cmm-assembly1.cif.gz_A Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine inhibitor	0.134	304	257	163	466	4	301	2.024E-08	232
LOKIASV2_1322_ESMFold_hypothetical_protein	3op5-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3op5-assembly2.cif.gz_B Human vaccinia-related kinase 1	0.139	304	257	163	466	3	302	1.484E-08	232
LOKIASV2_1322_ESMFold_hypothetical_protein	2gtn-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2gtn-assembly1.cif.gz_A Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717	0.151	318	253	167	484	5	303	2.075E-09	232
LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G5018	0.158	335	240	151	485	52	337	2.622E-08	232
LOKIASV2_1322_ESMFold_hypothetical_protein	2jam-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2jam-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase I G	0.148	295	210	176	470	6	253	2.622E-08	231
LOKIASV2_1322_ESMFold_hypothetical_protein	5g6v-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5g6v-assembly1.cif.gz_A Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	0.165	312	243	174	485	2	293	1.409E-08	231
LOKIASV2_1322_ESMFold_hypothetical_protein	2jii-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2jii-assembly2.cif.gz_B Structure of vaccinia related kinase 3	0.110	323	276	152	474	5	315	5.699E-08	231
LOKIASV2_1322_ESMFold_hypothetical_protein	3q5z-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3q5z-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain	0.140	325	261	151	475	31	335	7.011E-08	231
LOKIASV2_1322_ESMFold_hypothetical_protein	2w1z-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2w1z-assembly2.cif.gz_B ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	0.111	321	281	164	484	42	358	2.024E-08	231
LOKIASV2_1322_ESMFold_hypothetical_protein	4ihp-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4ihp-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	0.192	314	220	169	482	2	274	1.206E-08	231
LOKIASV2_1322_ESMFold_hypothetical_protein	4e5a-assembly1.cif.gz_X	LOKIASV2_1322_ESMFold_hypothetical_protein	4e5a-assembly1.cif.gz_X The W197A mutant of p38a MAP kinase	0.149	322	251	163	484	2	297	1.970E-09	230
LOKIASV2_1322_ESMFold_hypothetical_protein	3l9n-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3l9n-assembly1.cif.gz_A crystal structure of PKAB3 (pka triple mutant V123A, L173M, Q181K) with compound 27	0.134	332	257	154	485	11	308	1.562E-08	230
LOKIASV2_1322_ESMFold_hypothetical_protein	4z84-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4z84-assembly1.cif.gz_A PKAB3 in complex with pyrrolidine inhibitor 34a	0.148	329	236	154	482	11	288	9.310E-09	230
LOKIASV2_1322_ESMFold_hypothetical_protein	1r39-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1r39-assembly1.cif.gz_A THE STRUCTURE OF P38ALPHA	0.144	322	266	163	484	1	312	1.236E-09	230
LOKIASV2_1322_ESMFold_hypothetical_protein	5x3f-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5x3f-assembly1.cif.gz_B Crystal structure of the YgjG-Protein A-Zpa963-PKA catalytic domain	0.137	309	230	154	462	57	324	1.270E-08	230
LOKIASV2_1322_ESMFold_hypothetical_protein	4aw2-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	4aw2-assembly1.cif.gz_A-2 Crystal structure of CDC42 binding protein kinase alpha (MRCK alpha)	0.146	325	249	151	475	60	352	3.062E-08	230
LOKIASV2_1322_ESMFold_hypothetical_protein	8fe2-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8fe2-assembly2.cif.gz_B Structure of J-PKAc chimera complexed with Aplithianine A	0.139	329	238	154	482	77	354	2.761E-08	230
LOKIASV2_1322_ESMFold_hypothetical_protein	3qal-assembly1.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	3qal-assembly1.cif.gz_E Crystal Structure of Arg280Ala mutant of Catalytic subunit of cAMP-dependent Protein Kinase	0.133	324	253	150	473	4	296	8.841E-09	229
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2e-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6b2e-assembly1.cif.gz_A Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4.	0.125	455	369	167	621	1	423	3.759E-10	229
LOKIASV2_1322_ESMFold_hypothetical_protein	3c50-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3c50-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 2.6A	0.144	293	235	176	468	158	433	3.577E-08	229
LOKIASV2_1322_ESMFold_hypothetical_protein	1mry-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1mry-assembly1.cif.gz_A crystal structure of an inactive akt2 kinase domain	0.133	317	225	169	485	2	261	8.189E-08	228
LOKIASV2_1322_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP	0.148	301	228	176	476	7	275	1.117E-07	228
LOKIASV2_1322_ESMFold_hypothetical_protein	4c38-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4c38-assembly1.cif.gz_A PKA-S6K1 Chimera with compound 21e (CCT239066) bound	0.139	331	255	154	484	11	307	1.484E-08	228
LOKIASV2_1322_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_A Crystal structure of STING CTD in complex with TBK1	0.140	365	290	166	503	5	369	9.310E-09	228
LOKIASV2_1322_ESMFold_hypothetical_protein	3dae-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3dae-assembly1.cif.gz_A Crystal structure of phosphorylated SNF1 kinase domain	0.175	293	192	176	468	8	241	2.306E-07	227
LOKIASV2_1322_ESMFold_hypothetical_protein	4ae6-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4ae6-assembly1.cif.gz_A Structure and Function of the Human Sperm-Specific Isoform of Protein Kinase A (PKA) Catalytic Subunit Calpha 2	0.140	333	249	150	482	1	290	1.145E-08	227
LOKIASV2_1322_ESMFold_hypothetical_protein	4aa0-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4aa0-assembly1.cif.gz_A P38ALPHA MAP KINASE BOUND TO CMPD 2	0.144	296	235	167	462	5	279	4.067E-09	227
LOKIASV2_1322_ESMFold_hypothetical_protein	1ywr-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1ywr-assembly1.cif.gz_A Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor	0.153	322	257	163	484	1	304	8.841E-09	227
LOKIASV2_1322_ESMFold_hypothetical_protein	5wnh-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5wnh-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.157	335	255	151	485	52	355	4.178E-08	227
LOKIASV2_1322_ESMFold_hypothetical_protein	5ztn-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5ztn-assembly1.cif.gz_B The crystal structure of human DYRK2 in complex with Curcumin	0.169	303	242	176	467	90	392	3.577E-08	227
LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly3.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly3.cif.gz_E CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.172	350	270	169	518	1	327	2.075E-09	227
LOKIASV2_1322_ESMFold_hypothetical_protein	5o1v-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5o1v-assembly1.cif.gz_B Crystal structure of WNK3 kinase domain in a monophosphorylated apo state (A-loop swapped)	0.167	310	214	176	485	13	270	1.176E-07	226
LOKIASV2_1322_ESMFold_hypothetical_protein	8enj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8enj-assembly1.cif.gz_A Design, synthesis, biological evaluation, and X-ray crystallography of diarylpyrazole derivatives possessing terminal arylsulfonamide moieties as anti-proliferative agents targeting c-Jun N-terminal kinase (JNK)	0.160	328	261	167	478	5	332	6.480E-09	226
LOKIASV2_1322_ESMFold_hypothetical_protein	8acm-assembly1.cif.gz_AAA	LOKIASV2_1322_ESMFold_hypothetical_protein	8acm-assembly1.cif.gz_AAA Crystal structure of WT p38alpha	0.158	322	253	163	484	1	302	9.805E-09	226
LOKIASV2_1322_ESMFold_hypothetical_protein	4o2z-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	4o2z-assembly1.cif.gz_A-2 Crystal Structure of MPK3 from Leishmania donovani, LdBPK_100540 in the presence of NVP-BBT594	0.167	319	257	162	470	6	324	2.688E-09	226
LOKIASV2_1322_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_D Crystal Structure of ROCK 1 bound to YB-15-QD37	0.159	335	250	151	485	52	349	8.624E-08	226
LOKIASV2_1322_ESMFold_hypothetical_protein	2v55-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2v55-assembly1.cif.gz_A Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure	0.166	335	254	151	485	52	356	9.082E-08	226
LOKIASV2_1322_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 11	0.182	292	209	176	467	10	265	6.657E-08	225
LOKIASV2_1322_ESMFold_hypothetical_protein	6ac9-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6ac9-assembly4.cif.gz_D Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP	0.143	304	247	163	466	1	289	3.767E-08	225
LOKIASV2_1322_ESMFold_hypothetical_protein	6bru-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6bru-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a (S)-2-phenylaminopteridinone inhibitor	0.139	304	251	163	466	2	294	1.176E-07	225
LOKIASV2_1322_ESMFold_hypothetical_protein	6cmm-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6cmm-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine inhibitor	0.131	304	257	163	466	3	299	3.767E-08	225
LOKIASV2_1322_ESMFold_hypothetical_protein	2uzt-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2uzt-assembly1.cif.gz_A PKA structures of AKT, indazole-pyridine inhibitors	0.134	332	257	154	485	10	307	2.245E-08	225
LOKIASV2_1322_ESMFold_hypothetical_protein	7e11-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7e11-assembly1.cif.gz_A Crystal structure of PKAc-PLN R9C complex	0.144	333	246	150	482	1	288	5.268E-09	225
LOKIASV2_1322_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.159	307	240	176	482	12	297	1.033E-08	225
LOKIASV2_1322_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_B-2	LOKIASV2_1322_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_B-2 Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor	0.161	335	248	151	485	51	346	1.780E-07	225
LOKIASV2_1322_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_A Structure and Activation Mechanism of the CHK2 DNA-Damage Checkpoint Kinase	0.185	300	209	176	475	132	389	1.562E-08	225
LOKIASV2_1322_ESMFold_hypothetical_protein	5t6a-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5t6a-assembly1.cif.gz_A Crystal Structure of TgCDPK1 from toxoplasma gondii complexed with 5GA	0.184	308	231	169	476	1	284	1.270E-08	225
LOKIASV2_1322_ESMFold_hypothetical_protein	4usf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4usf-assembly1.cif.gz_A Human SLK with SB-440719	0.157	313	231	163	475	2	276	7.775E-08	224
LOKIASV2_1322_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2 Crystal structure of HPK1 in complex an inhibitor G1858	0.160	288	207	176	463	12	258	5.139E-08	224
LOKIASV2_1322_ESMFold_hypothetical_protein	6gu7-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6gu7-assembly1.cif.gz_A CDK1/Cks2 in complex with AZD5438	0.176	295	225	176	470	4	277	1.305E-07	224
LOKIASV2_1322_ESMFold_hypothetical_protein	1kv2-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1kv2-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with BIRB 796	0.141	321	249	164	484	1	291	8.395E-09	224
LOKIASV2_1322_ESMFold_hypothetical_protein	3gcp-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3gcp-assembly1.cif.gz_A Human P38 MAP Kinase in Complex with SB203580	0.144	308	253	163	470	1	297	5.002E-09	224
LOKIASV2_1322_ESMFold_hypothetical_protein	4lv8-assembly2.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4lv8-assembly2.cif.gz_A Murine IRGa6 bound to Toxoplasma ROP5C, a pseudokinase GDI	0.140	311	267	167	477	49	359	1.447E-07	224
LOKIASV2_1322_ESMFold_hypothetical_protein	2v55-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	2v55-assembly2.cif.gz_C Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure	0.171	335	252	151	485	52	356	8.624E-08	224
LOKIASV2_1322_ESMFold_hypothetical_protein	4ih8-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4ih8-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	0.180	308	231	169	476	1	283	5.002E-09	224
LOKIASV2_1322_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_A Crystal structure of SPAK (STK39) dimer in the basal activity state	0.154	295	233	176	470	11	286	2.364E-08	223
LOKIASV2_1322_ESMFold_hypothetical_protein	4izy-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4izy-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(4-Methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}-cyclohexan	0.149	311	250	164	474	1	295	9.310E-09	223
LOKIASV2_1322_ESMFold_hypothetical_protein	5ntj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5ntj-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compound RKp032	0.136	333	255	154	486	27	322	6.153E-09	223
LOKIASV2_1322_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_B Crystal Structure of ROCK 1 bound to YB-15-QD37	0.147	335	253	151	485	52	349	6.657E-08	223
LOKIASV2_1322_ESMFold_hypothetical_protein	3qfv-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3qfv-assembly1.cif.gz_B MRCK beta in complex with TPCA-1	0.154	324	246	152	475	60	351	1.117E-07	223
LOKIASV2_1322_ESMFold_hypothetical_protein	4ual-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	4ual-assembly1.cif.gz_A-2 MRCK beta in complex with BDP00005290	0.131	325	249	151	475	62	349	6.321E-08	223
LOKIASV2_1322_ESMFold_hypothetical_protein	4btf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4btf-assembly1.cif.gz_A Structure of MLKL	0.138	318	242	149	466	130	411	2.688E-09	223
LOKIASV2_1322_ESMFold_hypothetical_protein	3v5w-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3v5w-assembly1.cif.gz_A Human G Protein-Coupled Receptor Kinase 2 in Complex with Soluble Gbetagamma Subunits and Paroxetine	0.135	450	375	166	615	154	588	1.406E-10	223
LOKIASV2_1322_ESMFold_hypothetical_protein	3o51-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3o51-assembly1.cif.gz_A Crystal structure of anthranilamide 10 bound to AuroraA	0.153	300	203	169	468	3	243	1.524E-07	222
LOKIASV2_1322_ESMFold_hypothetical_protein	2c5y-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2c5y-assembly1.cif.gz_A DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN	0.166	294	229	176	469	4	279	8.189E-08	222
LOKIASV2_1322_ESMFold_hypothetical_protein	2gtm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2gtm-assembly1.cif.gz_A Mutated Mouse P38 MAP Kinase Domain in complex with Inhibitor PG-892579	0.134	322	265	163	484	1	307	4.283E-09	222
LOKIASV2_1322_ESMFold_hypothetical_protein	6sov-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6sov-assembly1.cif.gz_A Fragments KCL_615 and KCL_802 in complex with MAP kinase p38-alpha	0.153	318	254	167	484	4	304	1.645E-08	222
LOKIASV2_1322_ESMFold_hypothetical_protein	6eh3-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6eh3-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp190	0.127	333	258	154	486	27	322	5.843E-09	222
LOKIASV2_1322_ESMFold_hypothetical_protein	4zji-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4zji-assembly2.cif.gz_B PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	0.158	300	215	180	479	21	276	1.524E-07	221
LOKIASV2_1322_ESMFold_hypothetical_protein	6gu7-assembly4.cif.gz_G	LOKIASV2_1322_ESMFold_hypothetical_protein	6gu7-assembly4.cif.gz_G CDK1/Cks2 in complex with AZD5438	0.179	295	225	176	470	4	278	1.007E-07	221
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_F	LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_F Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	0.158	275	195	188	462	30	261	1.447E-07	221
LOKIASV2_1322_ESMFold_hypothetical_protein	6cnx-assembly4.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	6cnx-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase 1 (VRK1) bound to an N-propynyl-N-isopentyl-dihydropteridin inhibitor	0.137	303	254	164	466	1	295	1.305E-07	221
LOKIASV2_1322_ESMFold_hypothetical_protein	3zsi-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3zsi-assembly1.cif.gz_A X-ray structure of p38alpha bound to VX-745	0.150	318	245	167	484	4	292	1.825E-08	221
LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly2.cif.gz_C ROCK1 IN COMPLEX WITH LIGAND G5018	0.155	335	241	151	485	50	335	7.383E-08	221
LOKIASV2_1322_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A HPK1 IN COMPLEX WITH COMPOUND 11	0.178	292	209	176	467	11	265	1.239E-07	220
LOKIASV2_1322_ESMFold_hypothetical_protein	8fh4-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8fh4-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-[6-chloro-4-(9-methyl-1-oxa-4,9-diazaspiro[5.5]undec-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile	0.177	304	216	176	479	12	274	2.024E-08	220
LOKIASV2_1322_ESMFold_hypothetical_protein	5he2-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5he2-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224406	0.143	463	381	153	615	148	593	2.020E-10	220
LOKIASV2_1322_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP	0.169	311	224	160	470	3	272	4.178E-08	219
LOKIASV2_1322_ESMFold_hypothetical_protein	3o7l-assembly1.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	3o7l-assembly1.cif.gz_D Crystal Structure of phospholamban (1-19):PKA C-subunit:AMP-PNP:Mg2+ complex	0.154	333	244	150	482	1	289	1.374E-07	218
LOKIASV2_1322_ESMFold_hypothetical_protein	8fko-assembly3.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	8fko-assembly3.cif.gz_D Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(2S,5R)-5-Amino-2-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.167	292	207	176	467	13	262	1.176E-07	217
LOKIASV2_1322_ESMFold_hypothetical_protein	3ku2-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3ku2-assembly1.cif.gz_A Crystal Structure of inactivated form of CDPK1 from toxoplasma gondii, TGME49.101440	0.194	316	218	169	484	2	272	2.245E-08	217
LOKIASV2_1322_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	0.170	292	220	176	467	4	269	4.633E-08	216
LOKIASV2_1322_ESMFold_hypothetical_protein	4dfy-assembly2.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	4dfy-assembly2.cif.gz_E Crystal structure of R194A mutant of cAMP-dependent protein kinase with unphosphorylated activation loop	0.134	326	240	151	476	8	285	3.967E-08	216
LOKIASV2_1322_ESMFold_hypothetical_protein	6egw-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6egw-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp017 and RKp117	0.125	337	267	150	486	1	306	1.825E-08	216
LOKIASV2_1322_ESMFold_hypothetical_protein	3q60-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3q60-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain bound to ATP	0.138	326	273	152	477	32	349	1.176E-07	216
LOKIASV2_1322_ESMFold_hypothetical_protein	6s9w-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6s9w-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a	0.155	335	247	151	485	103	395	5.412E-08	216
LOKIASV2_1322_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.179	292	209	176	467	13	267	5.412E-08	215
LOKIASV2_1322_ESMFold_hypothetical_protein	2v62-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2v62-assembly2.cif.gz_B Structure of vaccinia-related kinase 2	0.126	305	256	163	467	1	294	8.624E-08	215
LOKIASV2_1322_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B Crystal structure of the kinase MARK3/Par-1: T211A-S215A double mutant	0.180	280	196	176	455	7	246	8.624E-08	215
LOKIASV2_1322_ESMFold_hypothetical_protein	3ncz-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3ncz-assembly1.cif.gz_B X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor	0.157	335	240	151	485	57	342	5.699E-08	215
LOKIASV2_1322_ESMFold_hypothetical_protein	5ote-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	5ote-assembly1.cif.gz_A-2 MRCK beta in complex with BDP-00008900	0.151	325	246	151	475	62	352	8.624E-08	215
LOKIASV2_1322_ESMFold_hypothetical_protein	3v51-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3v51-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with inhibitor RM-1-176	0.184	310	235	167	476	1	289	1.825E-08	214
LOKIASV2_1322_ESMFold_hypothetical_protein	5izj-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5izj-assembly2.cif.gz_B Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	0.142	309	229	154	462	11	278	3.396E-08	213
LOKIASV2_1322_ESMFold_hypothetical_protein	5izj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5izj-assembly1.cif.gz_A Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	0.148	327	233	156	482	14	288	1.645E-08	213
LOKIASV2_1322_ESMFold_hypothetical_protein	1rej-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1rej-assembly1.cif.gz_A Crystal structure of cAMP-dependent protein kinase complexed with balanol analog 1	0.132	332	254	154	485	9	302	5.139E-08	213
LOKIASV2_1322_ESMFold_hypothetical_protein	7ejv-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7ejv-assembly1.cif.gz_B The co-crystal structure of DYRK2 with YK-2-69	0.156	313	248	176	470	70	382	7.569E-09	213
LOKIASV2_1322_ESMFold_hypothetical_protein	2hak-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2hak-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.176	300	206	176	475	6	256	1.974E-07	212
LOKIASV2_1322_ESMFold_hypothetical_protein	8q1z-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8q1z-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to JA-296	0.129	305	256	163	467	1	295	1.374E-07	212
LOKIASV2_1322_ESMFold_hypothetical_protein	1ydt-assembly1.cif.gz_E	LOKIASV2_1322_ESMFold_hypothetical_protein	1ydt-assembly1.cif.gz_E STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE	0.141	317	242	154	470	10	292	5.412E-08	212
LOKIASV2_1322_ESMFold_hypothetical_protein	6erv-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6erv-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp013	0.131	323	256	151	473	17	312	2.761E-08	212
LOKIASV2_1322_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_B Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.161	310	242	176	485	18	306	1.562E-08	212
LOKIASV2_1322_ESMFold_hypothetical_protein	5jms-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5jms-assembly1.cif.gz_A Crystal structure of TgCDPK1 bound to CGP060476	0.177	308	235	169	476	2	287	1.270E-08	212
LOKIASV2_1322_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	0.138	292	208	176	467	3	244	2.987E-07	211
LOKIASV2_1322_ESMFold_hypothetical_protein	5w80-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5w80-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor GXJ-237	0.184	308	234	169	476	2	289	2.622E-08	211
LOKIASV2_1322_ESMFold_hypothetical_protein	7k7l-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.118	470	398	150	619	130	581	7.554E-11	211
LOKIASV2_1322_ESMFold_hypothetical_protein	2baq-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2baq-assembly1.cif.gz_A p38alpha bound to Ro3201195	0.147	322	252	163	484	1	296	2.245E-08	210
LOKIASV2_1322_ESMFold_hypothetical_protein	5wnh-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5wnh-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.156	335	234	151	485	53	330	6.657E-08	210
LOKIASV2_1322_ESMFold_hypothetical_protein	1kwp-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1kwp-assembly1.cif.gz_A Crystal Structure of MAPKAP2	0.158	292	197	188	479	31	265	1.447E-07	209
LOKIASV2_1322_ESMFold_hypothetical_protein	6vxu-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6vxu-assembly1.cif.gz_A Structure of Human Vaccinia-related Kinase 1 (VRK1) bound to ACH471	0.140	304	257	163	466	4	303	8.624E-08	209
LOKIASV2_1322_ESMFold_hypothetical_protein	5wg4-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5wg4-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257284	0.147	450	369	166	615	153	586	6.308E-10	209
LOKIASV2_1322_ESMFold_hypothetical_protein	6cqh-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6cqh-assembly1.cif.gz_A Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor	0.138	304	254	163	466	4	299	2.557E-07	208
LOKIASV2_1322_ESMFold_hypothetical_protein	2v62-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2v62-assembly1.cif.gz_A Structure of vaccinia-related kinase 2	0.122	305	256	163	467	1	293	1.176E-07	207
LOKIASV2_1322_ESMFold_hypothetical_protein	2w9f-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2w9f-assembly1.cif.gz_B Crystal Structure of CDK4 in complex with a D-type cyclin	0.197	295	207	176	470	2	260	2.693E-07	206
LOKIASV2_1322_ESMFold_hypothetical_protein	5awm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5awm-assembly1.cif.gz_A The Crystal Structure of JNK from Drosophila melanogaster Reveals an Evolutionarily Conserved Topology with that of Mammalian JNK Proteins.	0.149	314	264	167	477	3	316	4.400E-08	206
LOKIASV2_1322_ESMFold_hypothetical_protein	4eut-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4eut-assembly1.cif.gz_A Structure of BX-795 Complexed with Unphosphorylated Human TBK1 Kinase-ULD Domain	0.112	426	339	167	592	1	383	4.750E-09	206
LOKIASV2_1322_ESMFold_hypothetical_protein	1mrv-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	1mrv-assembly1.cif.gz_A crystal structure of an inactive Akt2 kinase domain	0.132	315	214	169	483	1	248	2.136E-06	205
LOKIASV2_1322_ESMFold_hypothetical_protein	6vph-assembly1.cif.gz_A-2	LOKIASV2_1322_ESMFold_hypothetical_protein	6vph-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 modified with cacodylate and in complex with AMP-PNP	0.171	302	209	169	470	23	275	3.313E-07	205
LOKIASV2_1322_ESMFold_hypothetical_protein	8fjz-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8fjz-assembly1.cif.gz_A Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.179	307	219	161	467	4	271	7.011E-08	205
LOKIASV2_1322_ESMFold_hypothetical_protein	4lgd-assembly6.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4lgd-assembly6.cif.gz_D Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.147	308	244	176	483	17	303	2.024E-08	205
LOKIASV2_1322_ESMFold_hypothetical_protein	6s9x-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6s9x-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 15c	0.159	335	232	151	485	91	367	1.007E-07	205
LOKIASV2_1322_ESMFold_hypothetical_protein	6hhj-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6hhj-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 24b	0.149	335	250	151	485	100	394	6.321E-08	205
LOKIASV2_1322_ESMFold_hypothetical_protein	4ifg-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4ifg-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	0.179	308	235	169	476	2	288	2.908E-08	205
LOKIASV2_1322_ESMFold_hypothetical_protein	4x21-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4x21-assembly1.cif.gz_A The MAP kinase JNK3 as target for halogen bonding	0.157	310	254	164	473	1	302	3.577E-08	204
LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G4998	0.157	335	245	151	485	50	341	3.870E-07	204
LOKIASV2_1322_ESMFold_hypothetical_protein	5w8r-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5w8r-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor 3CIB-PPI	0.191	308	234	169	476	2	291	1.270E-08	204
LOKIASV2_1322_ESMFold_hypothetical_protein	4oti-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4oti-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Tofacitinib	0.162	316	211	167	482	3	255	6.166E-07	203
LOKIASV2_1322_ESMFold_hypothetical_protein	4lv5-assembly2.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4lv5-assembly2.cif.gz_A Murine IRGa6 bound to Toxoplasma ROP5B, a pseudokinase GDI	0.137	326	274	151	476	30	348	1.605E-07	203
LOKIASV2_1322_ESMFold_hypothetical_protein	6hhg-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6hhg-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 27	0.141	317	225	169	485	108	370	2.557E-07	203
LOKIASV2_1322_ESMFold_hypothetical_protein	6byr-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6byr-assembly1.cif.gz_A Structures of the PKA RI alpha holoenzyme with the FLHCC driver J-PKAc alpha or native PKAc alpha	0.142	335	251	151	485	64	356	7.775E-08	203
LOKIASV2_1322_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	0.161	310	225	176	485	11	279	7.383E-08	202
LOKIASV2_1322_ESMFold_hypothetical_protein	2w99-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	2w99-assembly1.cif.gz_B Crystal Structure of CDK4 in complex with a D-type cyclin	0.163	295	239	176	470	5	290	6.494E-07	202
LOKIASV2_1322_ESMFold_hypothetical_protein	2o0u-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	2o0u-assembly1.cif.gz_A Crystal structure of human JNK3 complexed with N-{3-cyano-6-[3-(1-piperidinyl)propanoyl]-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl}-1-naphthalenecarboxamide	0.158	328	258	164	470	1	328	2.245E-08	202
LOKIASV2_1322_ESMFold_hypothetical_protein	6c9d-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6c9d-assembly2.cif.gz_B Crystal structure of KA1-autoinhibited MARK1 kinase	0.116	456	354	164	619	1	402	1.338E-08	202
LOKIASV2_1322_ESMFold_hypothetical_protein	6vxu-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6vxu-assembly3.cif.gz_C Structure of Human Vaccinia-related Kinase 1 (VRK1) bound to ACH471	0.134	304	252	163	466	3	294	3.674E-07	201
LOKIASV2_1322_ESMFold_hypothetical_protein	6bxi-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6bxi-assembly2.cif.gz_B X-ray crystal structure of NDR1 kinase domain	0.136	320	273	169	485	2	321	2.987E-07	201
LOKIASV2_1322_ESMFold_hypothetical_protein	5o5m-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5o5m-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp117	0.125	323	249	154	476	16	300	7.775E-08	201
LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_C ROCK1 IN COMPLEX WITH LIGAND G4998	0.155	335	241	151	485	45	330	3.489E-07	201
LOKIASV2_1322_ESMFold_hypothetical_protein	5wng-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5wng-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.152	335	238	151	485	53	334	5.013E-07	201
LOKIASV2_1322_ESMFold_hypothetical_protein	3i79-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3i79-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1)	0.174	308	240	169	476	1	292	5.412E-08	201
LOKIASV2_1322_ESMFold_hypothetical_protein	5o2b-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5o2b-assembly2.cif.gz_B Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121	0.163	287	199	176	462	12	250	5.560E-07	200
LOKIASV2_1322_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 7-(1-methyl-1H-pyrazol-4-yl)-N-[4-(1-methylpiperidin-4-yl)phenyl]quinazolin-2-amine	0.182	292	209	176	467	11	266	2.987E-07	198
LOKIASV2_1322_ESMFold_hypothetical_protein	3o96-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3o96-assembly1.cif.gz_A Crystal Structure of Human AKT1 with an Allosteric Inhibitor	0.140	335	230	151	485	98	366	4.760E-07	196
LOKIASV2_1322_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.139	334	215	151	484	53	303	1.176E-07	195
LOKIASV2_1322_ESMFold_hypothetical_protein	8elc-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8elc-assembly1.cif.gz_A Human JNK2 bound to covalent inhibitor YL2056	0.151	324	266	164	477	1	324	9.564E-08	195
LOKIASV2_1322_ESMFold_hypothetical_protein	6cnx-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6cnx-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase 1 (VRK1) bound to an N-propynyl-N-isopentyl-dihydropteridin inhibitor	0.128	304	254	163	466	3	294	6.494E-07	194
LOKIASV2_1322_ESMFold_hypothetical_protein	5kcv-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5kcv-assembly1.cif.gz_A Crystal structure of allosteric inhibitor, ARQ 092, in complex with autoinhibited form of AKT1	0.140	335	225	151	485	81	343	3.313E-07	194
LOKIASV2_1322_ESMFold_hypothetical_protein	7nh4-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7nh4-assembly1.cif.gz_A Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 3	0.142	335	237	151	485	91	367	2.190E-07	194
LOKIASV2_1322_ESMFold_hypothetical_protein	3i7b-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3i7b-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor NM-PP1	0.161	355	297	176	530	6	360	6.480E-09	194
LOKIASV2_1322_ESMFold_hypothetical_protein	5ukm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5ukm-assembly1.cif.gz_A bovine GRK2 in complex with human Gbetagamma subunits and CCG258208 (14as)	0.149	450	368	166	615	153	585	7.760E-10	193
LOKIASV2_1322_ESMFold_hypothetical_protein	1kwp-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	1kwp-assembly2.cif.gz_B Crystal Structure of MAPKAP2	0.169	307	211	162	468	8	262	8.412E-07	192
LOKIASV2_1322_ESMFold_hypothetical_protein	4ejn-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4ejn-assembly1.cif.gz_A Crystal structure of autoinhibited form of AKT1 in complex with N-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide	0.142	335	239	151	485	87	366	4.178E-08	192
LOKIASV2_1322_ESMFold_hypothetical_protein	6cqh-assembly3.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	6cqh-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor	0.127	304	251	163	466	3	291	9.329E-07	191
LOKIASV2_1322_ESMFold_hypothetical_protein	3aln-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3aln-assembly1.cif.gz_A Crystal Structure of human non-phosphorylated MKK4 kinase domain complexed with AMP-PNP	0.142	312	221	163	474	10	267	3.775E-06	190
LOKIASV2_1322_ESMFold_hypothetical_protein	8x5l-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	8x5l-assembly1.cif.gz_A The Crystal Structure of PRKACA from Biortus.	0.133	313	244	154	466	9	290	4.520E-07	190
LOKIASV2_1322_ESMFold_hypothetical_protein	8x5l-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	8x5l-assembly2.cif.gz_B The Crystal Structure of PRKACA from Biortus.	0.140	327	231	156	482	12	281	2.836E-07	189
LOKIASV2_1322_ESMFold_hypothetical_protein	5idp-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	5idp-assembly1.cif.gz_A CDK8-CYCC IN COMPLEX WITH (3-Amino-1H-indazol-5-yl)-[(S)-2-(4-fluoro-phenyl)-piperidin-1-yl]-methanone	0.139	335	284	151	485	5	335	6.494E-07	189
LOKIASV2_1322_ESMFold_hypothetical_protein	6hhf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6hhf-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor Borussertib	0.144	310	211	176	485	109	355	1.090E-06	188
LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G4998	0.156	335	237	151	485	51	332	1.273E-06	187
LOKIASV2_1322_ESMFold_hypothetical_protein	6hhh-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6hhh-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 31	0.140	332	229	154	485	104	370	3.313E-07	187
LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G5018	0.177	204	134	151	354	52	215	5.423E-06	183
LOKIASV2_1322_ESMFold_hypothetical_protein	3hdm-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3hdm-assembly1.cif.gz_A Crystal structure of serum and glucocorticoid-regulated kinase 1 in complex with compound 1	0.134	324	239	162	485	6	282	3.584E-06	170
LOKIASV2_1322_ESMFold_hypothetical_protein	3h4j-assembly3.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3h4j-assembly3.cif.gz_A crystal structure of pombe AMPK KDAID fragment	0.163	287	196	176	462	7	241	5.560E-07	170
LOKIASV2_1322_ESMFold_hypothetical_protein	2onl-assembly1.cif.gz_C	LOKIASV2_1322_ESMFold_hypothetical_protein	2onl-assembly1.cif.gz_C Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	0.143	287	218	190	476	22	276	2.627E-06	170
LOKIASV2_1322_ESMFold_hypothetical_protein	6o8c-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	6o8c-assembly1.cif.gz_B Crystal structure of STING CTT in complex with TBK1	0.133	345	286	164	494	1	345	8.412E-07	169
LOKIASV2_1322_ESMFold_hypothetical_protein	5ce3-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	5ce3-assembly2.cif.gz_D The Yersinia YopO - actin complex with MgADP	0.100	299	260	176	474	24	313	7.398E-06	167
LOKIASV2_1322_ESMFold_hypothetical_protein	2onl-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	2onl-assembly2.cif.gz_D Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	0.173	294	194	192	485	20	254	6.334E-06	160
LOKIASV2_1322_ESMFold_hypothetical_protein	6wjf-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6wjf-assembly1.cif.gz_A PKA RIIbeta holoenzyme with DnaJB1-PKAc fusion in fibrolamellar hepatoceullar carcinoma	0.150	297	218	164	460	87	343	7.025E-06	152
LOKIASV2_1322_ESMFold_hypothetical_protein	4ci6-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4ci6-assembly1.cif.gz_B Mechanisms of crippling actin-dependent phagocytosis by YopO	0.113	243	215	228	470	47	289	1.450E-05	143
LOKIASV2_1322_ESMFold_hypothetical_protein	4czy-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4czy-assembly1.cif.gz_B Complex of Neurospora crassa PAN2 (WD40-CS1) with PAN3 (pseudokinase and C-term)	0.113	334	255	150	483	3	291	1.009E-05	139
LOKIASV2_1322_ESMFold_hypothetical_protein	7szc-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	7szc-assembly1.cif.gz_A Crystal Structure Analysis of human PRPK complex with a compound	0.157	179	130	180	358	20	174	5.723E-04	137
LOKIASV2_1322_ESMFold_hypothetical_protein	4bwx-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	4bwx-assembly1.cif.gz_B Structure of Neurospora crassa PAN3 pseudokinase mutant	0.103	334	258	150	483	3	291	2.699E-05	137
LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G4998	0.204	181	114	151	331	49	192	2.374E-04	135
LOKIASV2_1322_ESMFold_hypothetical_protein	4bwk-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4bwk-assembly1.cif.gz_A Structure of Neurospora crassa PAN3 pseudokinase	0.118	333	250	151	483	3	286	4.529E-05	134
LOKIASV2_1322_ESMFold_hypothetical_protein	4czy-assembly1.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	4czy-assembly1.cif.gz_D Complex of Neurospora crassa PAN2 (WD40-CS1) with PAN3 (pseudokinase and C-term)	0.114	334	255	150	483	3	291	1.694E-05	134
LOKIASV2_1322_ESMFold_hypothetical_protein	6dfl-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6dfl-assembly1.cif.gz_A WaaP in complex with acyl carrier protein	0.092	314	195	165	478	26	241	5.023E-05	128
LOKIASV2_1322_ESMFold_hypothetical_protein	4bwp-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	4bwp-assembly1.cif.gz_A Structure of Drosophila Melanogaster PAN3 pseudokinase	0.097	323	247	161	483	1	274	1.490E-04	124
LOKIASV2_1322_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A Crystal structure of Rv3168 with ATP	0.096	335	297	151	485	4	332	9.368E-03	61
LOKIASV2_1322_ESMFold_hypothetical_protein	3d33-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3d33-assembly1.cif.gz_A Crystal structure of a duf3244 family protein with an immunoglobulin-like beta-sandwich fold (bvu_0276) from bacteroides vulgatus atcc 8482 at 1.70 A resolution	0.137	85	70	537	621	12	93	1.184E-01	56
LOKIASV2_1322_ESMFold_hypothetical_protein	3d33-assembly2.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3d33-assembly2.cif.gz_B Crystal structure of a duf3244 family protein with an immunoglobulin-like beta-sandwich fold (bvu_0276) from bacteroides vulgatus atcc 8482 at 1.70 A resolution	0.120	81	68	541	621	15	92	1.383E-01	54
LOKIASV2_1322_ESMFold_hypothetical_protein	3nrd-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	3nrd-assembly1.cif.gz_A Crystal structure of a histidine triad (HIT) protein (SMc02904) from SINORHIZOBIUM MELILOTI 1021 at 2.06 A resolution	0.101	102	88	164	265	1	99	8.913E-01	40
LOKIASV2_1322_ESMFold_hypothetical_protein	3i4s-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3i4s-assembly1.cif.gz_B CRYSTAL STRUCTURE OF HISTIDINE TRIAD PROTEIN blr8122 FROM Bradyrhizobium japonicum	0.110	94	77	172	265	11	97	3.798E+00	30
LOKIASV2_1322_ESMFold_hypothetical_protein	3ohe-assembly1.cif.gz_B	LOKIASV2_1322_ESMFold_hypothetical_protein	3ohe-assembly1.cif.gz_B Crystal structure of a Histidine triad protein (Maqu_1709) from Marinobacter aquaeolei VT8 at 1.20 A resolution	0.120	100	85	167	266	1	98	5.456E+00	27
LOKIASV2_1322_ESMFold_hypothetical_protein	6xms-assembly1.cif.gz_A	LOKIASV2_1322_ESMFold_hypothetical_protein	6xms-assembly1.cif.gz_A Structure of P5A-ATPase Spf1, AlF4-bound form	0.097	188	161	163	350	548	726	3.333E-01	27
LOKIASV2_1322_ESMFold_hypothetical_protein	1hwk-assembly1.cif.gz_D	LOKIASV2_1322_ESMFold_hypothetical_protein	1hwk-assembly1.cif.gz_D COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN	0.056	189	115	224	346	133	321	4.436E+00	15
